Anthony Fauci | Academic Influence

Q: What Schools Are Affiliated With Anthony Fauci

Anthony Fauci is affiliated with the following schools: College of the Holy Cross, Columbia University, Pennsylvania State University, University of Oxford, Weill Cornell Medicine, University of Pennsylvania, University of Genoa, University of Toronto, Georgetown University, George Washington University, McGill University

Why Is Anthony Fauci Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anthony Stephen Fauci is an American physician-scientist and immunologist serving as the director of the National Institute of Allergy and Infectious Diseases and the Chief Medical Advisor to the President.

(See a Problem?)

Anthony Fauci's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 (1998) (3674)
Wegener granulomatosis: an analysis of 158 patients. (1992) (2645)
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. (2010) (2144)
The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). (2010) (1933)
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. (1983) (1895)
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. (2010) (1873)
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. (2010) (1826)
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. (1997) (1809)
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. (1986) (1698)
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth (1986) (1672)
The challenge of emerging and re-emerging infectious diseases (2004) (1635)
Coronavirus Infections-More Than Just the Common Cold. (2020) (1565)
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. (1983) (1563)
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease (1993) (1560)
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. (1988) (1465)
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. (2008) (1387)
Helicobacter pylori in peptic ulcer disease. (1994) (1313)
Covid-19 — Navigating the Uncharted (2020) (1283)
The immunopathogenesis of human immunodeficiency virus infection. (1993) (1058)
Zika Virus in the Americas--Yet Another Arbovirus Threat. (2016) (917)
Host factors and the pathogenesis of HIV-induced disease (1996) (909)
Glucocorticosteroid therapy: mechanisms of action and clinical considerations. (1976) (907)
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. (1987) (902)
Corticosteroid‐Mediated Immunoregulation in Man (1982) (872)
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. (1998) (821)
Multifactorial nature of human immunodeficiency virus disease: implications for therapy. (1993) (820)
Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes (1988) (816)
The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. (2010) (785)
Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic Considerations (1984) (781)
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. (1999) (767)
Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals (2008) (759)
NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. (1982) (727)
WEGENER'S GRANULOMATOSIS: STUDIES IN EIGHTEEN PATIENTS AND A REVIEW OF THE LITERATURE (1973) (720)
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. (1986) (704)
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. (1989) (699)
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. (1985) (697)
Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV (1994) (679)
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. (1989) (667)
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. (1989) (657)
Ending the HIV Epidemic: A Plan for the United States. (2019) (645)
B cells in HIV infection and disease (2009) (643)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. (2010) (610)
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease (1990) (604)
The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. (1974) (567)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. (2010) (566)
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. (1986) (566)
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. (1989) (542)
Takayasu Arteritis (1994) (542)
Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms (1990) (524)
Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. (2005) (520)
Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. (1989) (520)
Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis (1996) (519)
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. (1996) (514)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. (2008) (509)
CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status (2004) (500)
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV* (2002) (497)
Sjögren's syndrome (Sicca syndrome): current issues. (1980) (494)
Endothelins, peptides with potent vasoactive properties, are produced by human macrophages (1990) (489)
Lymphoid organs function as major reservoirs for human immunodeficiency virus. (1991) (486)
The immunopathogenesis of HIV infection. (1989) (484)
Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. (1994) (463)
Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk (1997) (463)
The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands (2008) (457)
Toward an Understanding of the Correlates of Protective Immunity to HIV Infection (1996) (451)
The 1918 influenza pandemic: insights for the 21st century. (2007) (450)
Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. (1990) (444)
Emerging Infectious Diseases: Threats to Human Health and Global Stability (2013) (440)
Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. (1990) (420)
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy (1999) (418)
The perpetual challenge of infectious diseases. (2012) (411)
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy (2000) (405)
Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. (1995) (404)
Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus (1986) (396)
Mechanisms of glucocorticoid action on immune processes. (1979) (393)
Immunopathogenic Mechanisms of HIV Infection (1996) (389)
Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates (2003) (384)
AIDS: Re-emergence of HIV after stopping therapy (1999) (383)
Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. (1996) (383)
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor (1997) (382)
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. (1983) (379)
HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells (2008) (377)
Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines (1998) (373)
The persistent legacy of the 1918 influenza virus. (2009) (368)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection (2015) (366)
Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. (1994) (366)
A strategic approach to COVID-19 vaccine R&D (2020) (361)
Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. (1986) (355)
Infectious diseases: considerations for the 21st century. (2001) (355)
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. (2016) (353)
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. (1997) (351)
Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. (1989) (351)
Surgical Pathology of the Lung in Wegener's Granulomatosis: Review of 87 Open Lung Biopsies From 67 Patients (1991) (344)
Pathogenic mechanisms of HIV disease. (2011) (339)
Latent reservoirs of HIV: obstacles to the eradication of virus. (1999) (338)
Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow. (1975) (338)
New concepts in the immunopathogenesis of HIV infection. (1995) (333)
Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. (1991) (329)
HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. (2019) (329)
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. (1988) (325)
Takayasu's arteritis and its therapy. (1985) (324)
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. (2016) (323)
Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. (1988) (322)
HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals (2001) (321)
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. (1984) (318)
Interpretation of Head and Neck Biopsies in Wegener's Granulomatosis: A Pathologic Study of 126 Biopsies in 70 Patients (1990) (316)
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. (1988) (314)
Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. (2013) (312)
Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. (1991) (307)
Global Vaccine Action Plan 2011-2020. (2013) (306)
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. (1997) (303)
Ophthalmic involvement in acquired immunodeficiency syndrome. (1984) (297)
Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. (1990) (294)
The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. (1979) (289)
Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. (1975) (288)
An HIV vaccine--evolving concepts. (2007) (286)
Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. (1993) (285)
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection (1997) (281)
The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. (1977) (281)
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. (1996) (279)
Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. (1996) (278)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention (2011) (278)
The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1 (2009) (275)
Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. (1990) (273)
The AIDS epidemic--considerations for the 21st century. (1999) (273)
HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. (2005) (272)
Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. (1998) (272)
Universal voluntary testing and treatment for prevention of HIV transmission. (2009) (271)
Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. (1974) (271)
Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. (1984) (270)
A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases (2018) (269)
Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. (1993) (268)
Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. (1983) (268)
Isolated angiitis of the central nervous system. Prospective diagnostic and therapeutic experience. (1983) (262)
Emerging Pandemic Diseases: How We Got to COVID-19 (2020) (261)
Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects. (1981) (261)
What is a pandemic? (2009) (260)
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. (1995) (258)
A new immunodeficiency disorder in humans involving NK cells (1980) (254)
Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. (1997) (253)
Therapy of the hypereosinophilic syndrome. (1978) (252)
HIV Vaccine Research: The Way Forward (2008) (250)
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection (1997) (249)
Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infections. (1991) (248)
HIV and AIDS: 20 years of science (2003) (246)
Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus (1986) (246)
Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. (1994) (246)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. (2010) (245)
Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. (1986) (245)
The effect of cytokines and pharmacologic agents on chronic HIV infection. (1992) (244)
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. (2010) (241)
The Acquired Immunodeficiency Syndrome: An Update (1985) (240)
Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily (2004) (239)
Wegener's granulomatosis. (1974) (239)
B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. (2010) (238)
Antimicrobial Resistance. (2016) (236)
Wegener granulomatosis in children and adolescents: clinical presentation and outcome. (1993) (236)
Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. (1998) (233)
Both Memory and CD45RA+/CD62L+ Naive CD4+ T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals (1999) (233)
Host factors in the pathogenesis of HIV disease (1997) (232)
Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. (1998) (232)
Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy (2016) (230)
Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. (1988) (229)
Effect of tumor necrosis factor alpha on mitogen-activated human B cells (1987) (228)
Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases (2005) (226)
ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMA (1988) (225)
The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. (1992) (223)
Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus (1987) (223)
Emerging infections: a perpetual challenge (2008) (223)
Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function (1985) (222)
B Cells of HIV-1–Infected Patients Bind Virions through Cd21–Complement Interactions and Transmit Infectious Virus to Activated T Cells (2000) (222)
HARRISON'S PRINCIPLES OF INTERNAL MEDICINE, 13TH EDITION: (2004) (221)
Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. (1997) (221)
Race against time (2005) (220)
Immunopathogenesis of the Acquired Immunodeficiency Syndrome (1985) (220)
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. (2015) (215)
Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: Correlation with increased IL-7 (2006) (211)
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. (2002) (211)
Early antibody therapy can induce long-lasting immunity to SHIV (2017) (204)
Influenza vaccines for the future. (2010) (201)
Interferon-α in patients with asymptomatic human immunodeficiency virus (HIV) infection. (1990) (200)
Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. (1994) (199)
Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. (2007) (196)
Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals (2007) (193)
Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. (1998) (192)
Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. (1987) (191)
Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. (1995) (191)
Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. (1996) (191)
HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells (2007) (191)
Immunologic abnormalities in the acquired immunodeficiency syndrome. (1986) (191)
Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. (1990) (190)
Immunopathogenesis of HIV infection. (1996) (190)
Building a tuberculosis-free world: The Lancet Commission on tuberculosis (2019) (189)
Ebola--underscoring the global disparities in health care resources. (2014) (188)
SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities. (2021) (187)
EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO (1985) (186)
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection (2006) (185)
Pulmonary involvement in the collagen vascular diseases. (1979) (185)
Compromised B cell responses to influenza vaccination in HIV-infected individuals. (2005) (185)
Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. (1987) (184)
Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. (2003) (183)
Role of Lymphoid Organs in the Pathogenesis of Human Immunodeficiency Virus (HIV) Infection (1994) (182)
Chediak-Higashi gene in humans. I. Impairment of natural - killer function (1980) (180)
ERYTHEMA ELEVATUM DIUTINUM: SKIN AND SYSTEMIC MANIFESTATIONS, IMMUNOLOGIC STUDIES, AND SUCCESSFUL TREATMENT WITH DAPSONE (1977) (180)
Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease. (1989) (179)
CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. (1992) (179)
Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation. (1982) (179)
Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals (2003) (179)
HIV reservoirs as obstacles and opportunities for an HIV cure (2015) (178)
Dengue and hemorrhagic fever: a potential threat to public health in the United States. (2008) (178)
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. (2014) (177)
Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy (2016) (176)
Suppression of human B lymphocyte function by cyclophosphamide. (1982) (175)
Bioterrorism—a clear and present danger (2001) (175)
HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication (2002) (174)
Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor (1983) (171)
Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients. (1981) (171)
Human Cyclic Neutropenia: Clinical Review and Long-Term Follow-up of Patients (1981) (171)
Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine. (2018) (169)
Alteration of T-cell functions by infection with HTLV-I or HTLV-II. (1984) (169)
Thirty Years of HIV and AIDS: Future Challenges and Opportunities (2011) (169)
Enhanced: The Need for a Global HIV Vaccine Enterprise (2003) (169)
Impairment of neutrophil bactericidal capacity in patients with AIDS. (1988) (168)
Immune correlates of vaccine protection against HIV-1 acquisition (2015) (167)
NK cells in HIV infection: paradigm for protection or targets for ambush (2005) (167)
Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes (1976) (167)
Factitious fever and self-induced infection: a report of 32 cases and review of the literature. (1979) (166)
Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis. (1971) (165)
Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. (1985) (165)
NK cells in HIV infection: Paradigm for protection or targets for ambush (2005) (165)
Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. (1988) (164)
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. (1995) (164)
Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage (1991) (163)
Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein. (1987) (161)
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure (2012) (161)
Alternate-day prednisone therapy and human lymphocyte subpopulations. (1975) (161)
Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine (2010) (160)
Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. (1983) (160)
Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. (1986) (159)
Pandemic Influenza Threat and Preparedness (2006) (157)
Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study (1990) (156)
Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. (1976) (156)
Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy. (2011) (155)
Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry. (1997) (155)
Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals (1989) (154)
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. (1987) (153)
Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. (1987) (153)
Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells (1992) (153)
The management of subglottic stenosis in patients with wegener's granulomatosis (1992) (153)
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters (2001) (153)
Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. (2008) (152)
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. (1982) (152)
Dermatologic manifestations of the hypereosinophilic syndrome. (1978) (151)
Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. (1994) (151)
Immunopathogenic mechanisms of HIV infection. (1996) (150)
HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. (1995) (150)
Development of effective vaccines against pandemic influenza. (2006) (150)
CD8+ T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages (1996) (149)
CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. (2007) (148)
Lymphotoxin is an important T cell-derived growth factor for human B cells. (1987) (148)
Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. (1987) (148)
Comparison of the Effector Cells in Human Spontaneous Cellular Cytotoxicity and Antibody‐Dependent Cellular Cytotoxicity: Differential Sensitivity of Effector Cells to in Vivo and in Vitro Corticosteroids (1978) (147)
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study (2015) (147)
cDNA cloning of the B cell membrane protein CD22: a mediator of B-B cell interactions (1991) (147)
Cytokine modulation of HIV expression. (1993) (145)
Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. (2008) (145)
Activation of human B lymphocytes XVI. Cellular requirements, interactions, and immunoregulation of pokeweed mitogen-induced total-immunoglobulin producing plaque-forming cells in peripheral blood. (1980) (144)
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: Implications for antiviral therapy (1998) (144)
Polyangiitis overlap syndrome. Classification and prospective clinical experience. (1986) (142)
Clinical Pharmacokinetics of Suramin in Patients With HTLV‐III/LAV Infection (1986) (142)
Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. (1996) (142)
HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. (1996) (141)
Proliferative responses of normal human B lymphocytes. Development of an assay system for human B cell growth factor (BCGF). (1982) (139)
Insights into B cells and HIV‐specific B‐cell responses in HIV‐infected individuals (2013) (138)
Immunologic abnormalities in the acquired immunodeficiency syndrome. (1985) (138)
An HIV vaccine--challenges and prospects. (2008) (137)
The effect of Hydrocortisone on the kinetics of normal human lymphocytes. (1975) (137)
The effects of interleukin 1 on human B cell activation and proliferation. (1983) (136)
Harrisons principles of internal medicine - 15th edition (2001) (133)
Serologic and immunologic studies in patients with AIDS in North America and Africa (1987) (132)
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. (1993) (131)
Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population. (1990) (130)
Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. (1991) (130)
The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7 +/CD4+ T cells As Key Targets in Mucosal Transmission (2011) (129)
IMMUNOFLUORESCENT STUDIES IN ADULT CELIAC DISEASE. (1965) (127)
AIDS--an immunologic reevaluation. (1984) (127)
Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. (1985) (126)
Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma. (1989) (125)
The Pathway to a Universal Influenza Vaccine. (2017) (125)
Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. (1978) (125)
Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. (2011) (125)
Both a precursor and a mature population of dendritic cells can bind HIV. However, only the mature population that expresses CD80 can pass infection to unstimulated CD4+ T cells. (1995) (124)
Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. (1988) (124)
A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes (1991) (124)
Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. (2001) (123)
Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. (1989) (123)
Immunoglobulin replacement therapy by slow subcutaneous infusion. (1980) (122)
Activation of human B lymphocytes. II. Cellular interactions in the PFC response of human tonsillar and peripheral blood B lymphocytes to polyclonal activation by pokeweed mitogen. (1976) (122)
Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis (2000) (122)
Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. (1991) (121)
Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. (1990) (121)
The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation (1996) (120)
Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation. (1985) (120)
Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research. (2008) (120)
B cell lines as models for inherited phagocytic diseases: abnormal superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syndrome. (1984) (119)
SARS-CoV-2 Viral Variants-Tackling a Moving Target. (2021) (119)
Immunopathogenesis of HIV infection (1991) (119)
Vitamin and trace Mineral Deficiency and Excess (2008) (118)
Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. (2007) (118)
CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. (1990) (117)
Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. (2000) (117)
In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements (1981) (117)
The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage. (1984) (116)
HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV (2011) (116)
Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. (1997) (115)
The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. (1990) (115)
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection (2014) (114)
The in vitro regulation of human thyrocyte HLA-DR antigen expression. (1985) (113)
Emerging and Re-Emerging Infectious Diseases: Influenza as a Prototype of the Host-Pathogen Balancing Act (2006) (113)
The Role of CD4+ T Cell Help and CD40 Ligand in the In Vitro Expansion of HIV-1-Specific Memory Cytotoxic CD8+ T Cell Responses (2000) (113)
The syndrome of Kaposi's sarcoma and opportunistic infections: an epidemiologically restricted disorder of immunoregulation. (1982) (112)
Cyclophosphamide-induced remissions in advanced polyarteritis nodosa. (1978) (112)
Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function (2003) (112)
Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission (1991) (111)
Frequency of myocarditis, left ventricular dysfunction and ventricular tachycardia in the acquired immune deficiency syndrome. (1988) (110)
Lysis of Endogenously Infected CD4+ T Cell Blasts by rIL-2 Activated Autologous Natural Killer Cells from HIV-Infected Viremic Individuals (2008) (109)
A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells (1994) (109)
Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. (1999) (108)
The next influenza pandemic: can it be predicted? (2007) (107)
Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals. (2014) (106)
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. (1987) (106)
Human B lymphoma cell line producing B cell growth factor. (1985) (106)
Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis. (1979) (106)
Mechanisms of the immunosuppressive and anti-inflammatory effects of glucocorticosteroids. (1978) (106)
Yellow Fever - Once Again on the Radar Screen in the Americas. (2017) (106)
Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. (1998) (105)
CCR5 Signal Transduction in Macrophages by Human Immunodeficiency Virus and Simian Immunodeficiency Virus Envelopes (2000) (105)
A potential role for adrenocorticotropin in regulating human B lymphocyte functions. (1985) (105)
Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation. (1977) (103)
Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera. (1999) (102)
Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome. (1981) (102)
Induction of expression of HIV in latently or chronically infected cells. (1989) (102)
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States (2015) (102)
HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. (2007) (102)
Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. (1988) (102)
Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. (1985) (102)
Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease. (1991) (101)
Chikungunya at the door--déjà vu all over again? (2014) (101)
B‐cell responses to HIV infection (2017) (100)
Differential expression of cell activation markers after stimulation of resting human B lymphocytes. (1984) (100)
Emerging Viral Diseases: Confronting Threats with New Technologies (2014) (100)
Measles in 2019 - Going Backward. (2019) (100)
Emerging and Reemerging Infectious Diseases: The Perpetual Challenge (2005) (100)
Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals (2003) (99)
Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. (2002) (99)
Immunopathogenesis of the acquired immunodeficiency syndrome. (1986) (98)
Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products. (1984) (98)
Death in the AIDS patient: role of cytomegalovirus. (1983) (98)
High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. (1983) (97)
Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells. (1987) (97)
Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern United States. (1982) (96)
Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1 (1991) (96)
Impact of HIV on Cell Survival and Antiviral Activity of Plasmacytoid Dendritic Cells (2007) (96)
A histamine-releasing factor from activated human mononuclear cells. (1985) (96)
Effects of in vivo prednisone on in vitro eosinophil and neutrophil adherence and chemotaxis. (1979) (95)
Further studies of the role of transforming growth factor-beta in human B cell function. (1989) (95)
Therapy for Early COVID-19: A Critical Need. (2020) (95)
Experience with surgical treatment of Takayasu's disease. (1991) (95)
Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy. (2012) (95)
Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression. (1989) (94)
Immunomodulators in Clinical Medicine (1987) (94)
Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. (1992) (94)
Cutaneous pathology in Wegener's granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. (1995) (93)
Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals. (1975) (91)
Effect of Immune Activation on the Dynamics of Human Immunodeficiency Virus Replication and on the Distribution of Viral Quasispecies (1998) (91)
Monoclonal Antibodies for Emerging Infectious Diseases - Borrowing from History. (2018) (90)
IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. (1995) (90)
Developmental therapeutics and the acquired immunodeficiency syndrome. (1987) (90)
Polyclonal activation of bone-marrow-derived lymphocytes from human peripheral blood measured by a direct plaque-forming cell assay. (1976) (90)
Selective suppression of an early step in human B cell activation by cyclosporin A (1983) (90)
Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL. (1985) (89)
Development of a human T-T cell hybridoma secreting B cell growth factor. (1983) (89)
Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. (1994) (89)
Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters. (2003) (89)
IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. (1991) (89)
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection (2017) (88)
The role of monocyte/macrophages and cytokines in the pathogenesis of HIV infection. (1992) (88)
Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. (1997) (88)
T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations. (1982) (88)
Cross-linking of CD30 induces HIV expression in chronically infected T cells. (1995) (87)
Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. (1989) (87)
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. (1985) (87)
Seasonal and pandemic influenza preparedness: science and countermeasures. (2006) (87)
Ending AIDS--is an HIV vaccine necessary? (2014) (87)
A simple method for the determination of complement receptor-bearing mononuclear cells. (1976) (86)
Comprar Harrison's Principles of Internal Medicine. 18th Ed. 2 Volúmenes | Dennis Kasper | 9780071748896 | Mcgraw-Hill Education (2011) (86)
Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome. (1978) (86)
CD4+ T-lymphocytopenia without HIV infection--no lights, no camera, just facts. (1993) (86)
Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells. (1992) (86)
Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. (1976) (85)
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection. (2002) (85)
The challenge of emerging and re-emerging infectious diseases (2010) (85)
Ear disease in patients with wegener's granulomatosis (1982) (85)
Defective HIV-1 proviruses produce viral proteins (2020) (84)
Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse (2014) (84)
Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)–infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I–uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1 (1998) (83)
Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. (1988) (83)
USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry. (1999) (82)
Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression. (1995) (82)
Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV. (1998) (82)
Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. (2004) (82)
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication (2010) (82)
A Way Forward: The National HIV/AIDS Strategy and Reducing HIV Incidence in the United States (2010) (82)
Alternate-day corticosteroid therapy. (1978) (81)
Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins. (1994) (81)
Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms (2006) (81)
Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. (1983) (81)
Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma. (1988) (80)
Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids. (1984) (80)
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor (2012) (80)
Smallpox vaccination policy--the need for dialogue. (2002) (79)
Innate Immune Dysfunction in HIV Infection: Effect of HIV Envelope-NK Cell Interactions12 (2006) (79)
Unusual radiographic features of Wegener's granulomatosis. (1978) (79)
Toward an AIDS-free generation. (2012) (79)
Ending the HIV/AIDS Pandemic (2018) (79)
Role of complement in host defense against experimental disseminated candidiasis. (1978) (79)
Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle (1987) (78)
The perpetual challenge of antimicrobial resistance. (2014) (78)
Paucity of HIV DNA Methylation in Latently Infected, Resting CD4+ T Cells from Infected Individuals Receiving Antiretroviral Therapy (2012) (78)
Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. (1981) (78)
Renal biopsy pathology in Wegener's granulomatosis. (1974) (77)
Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunity. (1975) (77)
Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies. (2001) (77)
Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor (1985) (77)
The role of lymphoid organs in the pathogenesis of HIV infection. (1993) (77)
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes (2001) (77)
HIV-1 gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression (2013) (76)
Emerging Infectious Diseases in 2012: 20 Years after the Institute of Medicine Report (2012) (76)
Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. (2002) (76)
Immunoregulation in autoimmunity. (1980) (76)
IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. (2012) (76)
Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes (2018) (75)
Tumor necrosis factor a induces expression of human immunodeficiency virus in a chronically infected T-cell clone (75)
Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice. (1979) (75)
Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation. (1981) (74)
Antigen-specific human T-cell clones: development of clones requiring HLA-DR-compatible presenting cells for stimulation in presence of antigen. (1981) (74)
Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells (1990) (74)
B-cell exhaustion in HIV infection: the role of immune activation (2014) (73)
Ending the HIV-AIDS Pandemic--Follow the Science. (2015) (73)
Cutaneous Pathology in Wegener's Granulomatosis (1995) (73)
Letter: Pulmonary aspergillosis, inhalation of contaminated marijuana smoke, chronic granulomatous disease. (1975) (73)
Dengue research opportunities in the Americas. (2012) (72)
Tickborne Diseases - Confronting a Growing Threat. (2018) (72)
Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir (2014) (72)
Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. (2012) (72)
Immune Activation with HIV Vaccines (2014) (72)
Intradermal influenza vaccination--can less be more? (2004) (71)
Decreased nucleotide and serotonin storage associated with defective function in Chediak-Higashi syndrome cattle and human platelets. (1976) (71)
Asthma in the inner city: the perspective of the National Institute of Allergy and Infectious Diseases. (2010) (71)
Transmission of multidrug-resistant human immunodeficiency virus--the wake-up call. (1998) (71)
Current therapy in allergy, immunology, and rheumatology (1988) (71)
Radiation therapy of midline granuloma. (1976) (71)
HIV-1 Vaccines and Adaptive Trial Designs (2011) (70)
Apoptosis in HIV infection (1995) (70)
Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. (2006) (69)
Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects. (1997) (69)
CD40-Mediated Induction of CD4 and CXCR4 on B Lymphocytes Correlates with Restricted Susceptibility to Human Immunodeficiency Virus Type 1 Infection: Potential Role of B Lymphocytes as a Viral Reservoir (1999) (69)
Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. (2005) (68)
Differential effect of monoclonal anti-DR antibody on monocytes in antigen- and mitogen-stimulated responses: mechanism of inhibition and relationship to interleukin 1 secretion. (1983) (68)
Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases. (2018) (68)
R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells. (2006) (68)
Heat shock induction of HIV production from chronically infected promonocytic and T cell lines. (1990) (67)
Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. (2004) (67)
The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammator (1998) (66)
Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. (1987) (66)
Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis. Clinical, pathologic, and immunologic features. (1987) (66)
CXCR4 and CCR5 Genetic Polymorphisms in Long-Term Nonprogressive Human Immunodeficiency Virus Infection: Lack of Association with Mutations other than CCR5-Δ32 (1998) (65)
Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual (1982) (65)
Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells (1991) (65)
Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms. (1999) (64)
Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig. (1984) (64)
Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. (1990) (63)
The need for a global HIV vaccine enterprise. Policy forum. (2003) (63)
The relationship between antibody affinity and the efficiency of complement fixation. (1970) (63)
In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. (1990) (62)
Efficacy of intermittent colchicine therapy in familial Mediterranean fever. (1977) (61)
Pandemic influenza viruses--hoping for the road not taken. (2013) (61)
Targeting alpha(4)beta(7) integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection (61)
Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. (1991) (61)
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. (1984) (61)
Comorbidities in Persons With HIV: The Lingering Challenge. (2019) (61)
Idiopathic midline destructive disease (IMDD): a subgroup of patients with the "midline granuloma" syndrome. (1982) (60)
Hydrocortisone-mediated inhibition of monocyte antigen presentation: dissociation of inhibitory effect and expression of DR antigens. (1984) (60)
Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus. (1982) (60)
Association between Takayasu's arteritis and a B-cell alloantigen in North Americans. (1982) (60)
Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations. (1980) (60)
An improved technique for the negative selection of large numbers of human lymphocytes and monocytes by counterflow centrifugation--elutriation. (1980) (59)
Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding. (1988) (59)
CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages. (1996) (58)
A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection. (2004) (58)
Considerations for Developing a Zika Virus Vaccine. (2016) (58)
Mechanisms of corticosteroid action on lymphocyte subpopulations. VI. Lack of correlation between glucocorticosteroid receptors and the differential effects of glucocorticosteroids on T-cell subpopulations. (1980) (58)
H7N9 Avian Influenza A Virus and the Perpetual Challenge of Potential Human Pandemicity (2013) (58)
B cell growth factor and T cell growth factor produced by mitogen-stimulated normal human peripheral blood T lymphocytes are distinct molecules. (1982) (58)
The Bb fragment of complement factor B acts as a B cell growth factor (1988) (57)
The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis. (1986) (57)
Human B Cell Function in a Polyclonally Induced Plaque Forming Cell System. Cell Triggering and Immunoregulation (1979) (57)
Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion. (1979) (57)
Immunohistochemical characterization of intrathyroid lymphocytes in Graves' disease. Interstitial and intraepithelial populations. (1984) (57)
Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations. (1975) (57)
Interleukin 1 Induces HIV-1 Expression in Chronically Infected U1 Cells: Blockade by Interleukin 1 Receptor Antagonist and Tumor Necrosis Factor Binding Protein Type 1 (1995) (56)
Immunological reactivity of the lung. I. A guinea pig model for the study of pulmonary mononuclear cell subpopulations. (1976) (56)
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals (2007) (56)
An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic. (2017) (56)
Bioterrorism on the home front: a new challenge for American medicine. (2001) (56)
Direct effects of a monoclonal B cell differentiation factor and of purified interleukin 1 on B cell differentiation. (1984) (56)
Effect of antiretroviral therapy on HIV reservoirs in elite controllers. (2013) (56)
Productive HIV infection of resting CD4+ T cells: role of lymphoid tissue microenvironment and effect of immunomodulating agents. (2003) (56)
Complement subcomponent C1q stimulates Ig production by human B lymphocytes. (1991) (56)
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. (1997) (56)
Characterization of Plasmablasts in the Blood of HIV-Infected Viremic Individuals: Evidence for Nonspecific Immune Activation (2013) (55)
New and reemerging diseases: the importance of biomedical research. (1998) (55)
Novel vaccine technologies for the 21st century (2019) (55)
The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance. (2008) (55)
Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion. (1989) (54)
Antigen-induced in vitro antibody production in humans: tetanus toxoid-specific antibody synthesis. (1982) (54)
Delineation of optimal conditions for producing mouse-human heterohybridomas from human peripheral blood B cells of immunized subjects. (1983) (54)
Adjuvant effect of cholera enterotoxin on the immune response of the mouse to sheep red blood cells. (1972) (54)
Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle. (1984) (54)
Twenty-Five Years of HIV/AIDS (2006) (53)
Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis. (1978) (53)
Pandemic influenza's 500th anniversary. (2010) (53)
Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy (2003) (52)
Production of B cell growth factor by normal human B cells. (1986) (52)
Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? (1994) (52)
25 years of HIV (2008) (52)
Oligoclonal immunoglobulins in patients with the acquired immunodeficiency syndrome. (1985) (52)
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation (2006) (52)
Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. (1994) (52)
Identification of multiple and distinct CD8+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation. (1996) (52)
Wegener's granulomatosis and related diseases. (1977) (52)
Use of interleukin-2 in patients with acquired immunodeficiency syndrome. (1984) (51)
HIV Envelope Induces Virus Expression from Resting CD4+ T Cells Isolated from HIV-Infected Individuals in the Absence of Markers of Cellular Activation or Apoptosis1 (2003) (51)
Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells (2009) (51)
Biochemical and Biological Characterization of a Dodecameric CD4-Ig Fusion Protein (2002) (51)
Immunologic reactivity of the lung. III. Effects of corticosteroids on alveolar macrophage cytotoxic effector cell function. (1977) (51)
Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1 (1997) (51)
Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. (1990) (51)
Transforming Growth Factor‐β Is a Potent Negative Regulator of Human Lymphocytes (1991) (50)
Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants (1993) (50)
Phenotypic characterization of human cytolytic T lymphocytes in mixed lymphocyte culture (1981) (50)
Direct effect of interleukin 2 on the differentiation of human B cells which have not been preactivated in vitro (1985) (50)
Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation. (1980) (50)
HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells. (2006) (50)
MALIGNANCIES IN THE AIDS PATIENT: NATURAL HISTORY, TREATMENT STRATEGIES, AND PRELIMINARY RESULTS (1984) (49)
Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis. (1993) (49)
HIV vaccine development--improving on natural immunity. (2011) (49)
Peripheral neuropathy in hypereosinophilic syndrome (1985) (49)
Correction of human cyclic neutropenia with prednisolone. (1978) (49)
Activation and regulation of human immune responses: implications in normal and disease states. (1983) (49)
Thymic microenvironment induces HIV expression. Physiologic secretion of IL-6 by thymic epithelial cells up-regulates virus expression in chronically infected cells. (1991) (49)
Mechanisms of corticosteroid action on lymphocyte subpopulations. III. Differential effects of dexamethasone administration on subpopulations of effector cells mediating cellular cytotoxicity in man. (1978) (49)
Activation of human B lymphocytes. VIII. Differential radiosensitivity of subpopulations of lymphoid cells involved in the polyclonally-induced PFC responses of peripheral blood B lymphocytes. (1978) (49)
SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn (2021) (48)
gp120 is present on the plasma membrane of apoptotic CD4 cells prepared from lymph nodes of HIV‐1‐infected individuals: an immunoelectron microscopic study (1997) (48)
B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells (1987) (47)
Resistance to HIV–1 infection: It's in the genes (1996) (47)
CD40 Ligand Trimer and IL-12 Enhance Peripheral Blood Mononuclear Cells and CD4+ T Cell Proliferation and Production of IFN-γ in Response to p24 Antigen in HIV-Infected Individuals: Potential Contribution of Anergy to HIV-Specific Unresponsiveness (2000) (47)
Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation. (1986) (47)
Rapid latex agglutination assay using recombinant envelope polypeptide for the detection of antibody to the HIV. (1988) (47)
Chronic granulomatous disease. Diagnosis in a 27-year-old man with Mycobacterium fortuitum. (1975) (47)
Relationship between alternate-day corticosteroid therapy and behavioral abnormalities. (1982) (47)
Opioids and Infectious Diseases: A Converging Public Health Crisis. (2019) (47)
High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy. (1982) (46)
Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretion. (1991) (46)
Selective pressure exerted by immunodominant HIV‐1‐specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope (1999) (46)
Eosinophil kinetics in the hypereosinophilic syndrome. (1976) (46)
Human Immunodeficiency Virus Type 1 Bound to B Cells: Relationship to Virus Replicating in CD4+ T Cells and Circulating in Plasma (2002) (46)
The 2009 H1N1 Pandemic Influenza Virus: What Next? (2010) (46)
Immunopathogenesis of HIV Infection (1993) (45)
Ending the global HIV/AIDS pandemic: the critical role of an HIV vaccine. (2014) (45)
Ocular findings in patients with neutrophil dysfunction. (1983) (45)
Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome. (1986) (45)
Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions. (1995) (45)
Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection (1997) (45)
Interleukin-2 and human immunodeficiency virus infection: Pathogenic mechanisms and potential for immunologic enhancement (1996) (45)
The T cell receptor Vβ repertoire in HIV-1 infection and disease (1993) (45)
Cathepsin G, a Neutrophil-Derived Serine Protease, Increases Susceptibility of Macrophages to Acute Human Immunodeficiency Virus Type 1 Infection (2000) (45)
Malaria control, elimination, and eradication: the role of the evolving biomedical research agenda. (2009) (44)
NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. (1991) (44)
Human B cell activation and cell cycle progression: stimulation with anti‐μ and Staphylococcus aureus Cowan strain I (1984) (44)
Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. (2004) (44)
Intercellular adhesion molecules (ICAM)‐1 ICAM‐2 and ICAM‐3 function as counter‐receptors for lymphocyte function‐associated molecule 1 in human immunodeficiency virus‐mediated syncytia formation (1994) (44)
Disseminated candidiasis. i. an experimental model in the guinea pig. (1975) (44)
The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells. (2002) (44)
Accumulation of human immunodeficiency virus‐specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection (1997) (44)
CpG Oligonucleotides Enhance Proliferative and Effector Responses of B Cells in HIV-Infected Individuals1 (2008) (44)
Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes. (1983) (43)
Immunologic reactivity in the hypereosinophilic syndrome. (1979) (43)
A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS. (2016) (43)
Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. (1996) (43)
Prospects for an HIV vaccine: leading B cells down the right path (2011) (43)
Cell-mediated immune responses in humans after induced infection with influenza A virus. (1977) (42)
Activation of human B lymphocytes (1978) (42)
A platelet abnormality in the Chediak-Higashi syndrome of man. (1976) (42)
Benefits and Risks of Influenza Research: Lessons Learned (2012) (42)
Presence of intracytoplasmic IgG in the lymphocytic infiltrates of the minor salivary glands of patients with primary Sjögren's syndrome. (1983) (42)
The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system. (1987) (42)
HIV-AIDS: much accomplished, much to do (2013) (42)
Innate Immunity in HIV Infection: Enhanced Susceptibility to CD95-Mediated Natural Killer Cell Death and Turnover Induced by HIV Viremia (2007) (42)
The role of lymphoid organs in the immunopathogenesis of HIV infection (1992) (42)
Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy. (2005) (42)
Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions. (2020) (42)
Experimental disseminated candidiasis. II. Administration of glucocorticosteroids, susceptibility to infection, and immunity. (1975) (42)
Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys. (1997) (41)
Polyarteritis nodosa, hairy cell leukemia and splenosis. (1981) (41)
The effect of cyclophosphamide on leukocyte kinetics and susceptibility to infection in patients with Wegener's granulomatosis. (1973) (41)
In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+ T cells after bacterial stimulation. (2000) (41)
Ethics of clinical research in the developing world (2002) (41)
Immunologic reconstitution in the acquired immunodeficiency syndrome. (1985) (41)
Functional correlates of lung involvement in Wegener's granulomatosis. Use of pulmonary function tests in staging and follow-up. (1980) (41)
Characterization of lymphocytes in bronchial lavage fluid from monkeys. (1976) (41)
Four Decades of HIV/AIDS - Much Accomplished, Much to Do. (2020) (40)
Activation and immunoregulation of antigen-specific human b lymphocyte responses: multifaceted role of the monocyte. (1982) (40)
Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing (2017) (40)
4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin (1984) (40)
The story behind COVID-19 vaccines (2021) (40)
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. (2009) (39)
Severe Meningoencephalitis in a Case of Ebola Virus Disease: A Case Report (2016) (39)
Recombinant interleukin 2 and gamma-interferon act synergistically on distinct steps of in vitro terminal human B cell maturation. (1986) (39)
Recurrence of Wegener's granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide. (1980) (39)
Recombinant interleukin-2-induced polyclonal proliferation of in vitro unstimulated human peripheral blood lymphocytes. (1986) (38)
Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome. Evidence for an abnormality affecting individual helper and suppressor T cells. (1985) (38)
Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. (1996) (38)
Immunosuppressive and anti-inflammatory effects of glucocorticoids. (1979) (38)
Eastern Equine Encephalitis Virus - Another Emergent Arbovirus in the United States. (2019) (38)
Universal Coronavirus Vaccines - An Urgent Need. (2021) (37)
Pathogenesis of HIV disease: opportunities for new prevention interventions. (2007) (37)
Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis. (1974) (37)
Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine. (1984) (36)
Pathogenic insights from studies of lymphoid tissue from HIV-infected individuals. (1995) (36)
Chronic, recurrent small-vessel cutaneous vasculitis. Clinical experience in 13 patients. (1982) (36)
Activated human T cells can present denatured antigen. (1986) (36)
Response: The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis (1988) (36)
Early Treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection (2017) (36)
Harrison's Infectious Diseases (2010) (36)
Conducting clinical trials in outbreak settings: Points to consider (2016) (35)
Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid. (1997) (35)
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation (2006) (35)
Harrison's rheumatology (2010) (35)
Role for CD21 in the Establishment of an Extracellular HIV Reservoir in Lymphoid Tissues1 (2007) (35)
Immunopathogenesis of human immunodeficiency virus infection. (1993) (35)
Wegener's granulomatosis (1980) (35)
Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infections (1988) (35)
Unusual etiologies of fever and their evaluation. (1975) (34)
Activation of human B lymphocytes. XI. Differential effects of azathioprine on B lymphocytes and lymphocyte subpopulations regulating B cell function. (1978) (34)
Necrotizing vasculitis, coronary angiitis, and the cardiologist. (1980) (34)
Pulmonary Involvement in the Collagen Vascular Diseases1,2 (2015) (34)
Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection. (2009) (34)
Influenza Vaccines: Good, but We Can Do Better. (2019) (34)
Neuropsychiatric aspects of AIDS. (1986) (34)
Sequential synergistic effect of interleukin 2 and interferon-gamma on the differentiation of a Tac-antigen-positive B cell line. (1986) (34)
Astrocyte-conditioned medium stimulates HIV-1 expression in a chronically infected promonocyte clone (1990) (34)
Isolation and Quantitation of HIV in Peripheral Blood (1993) (34)
Development of a human T-cell hybridoma secreting separate B-cell growth and differentiation factors. (1984) (34)
Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression (1995) (34)
Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes. (1991) (34)
What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats (2017) (34)
A Randomized, Controlled, Trial of Short Cycle Intermittent Compared to Continuous Antiretroviral Therapy for the Treatment of HIV Infection in Uganda (2010) (33)
HIV‐1 infection in the lymphoid organs (1993) (33)
Successful renal transplantation in Wegener's granulomatosis. (1976) (33)
Tracking HIV during disease progression. (1994) (33)
Research in the Context of a Pandemic (2020) (33)
Toward an HIV vaccine: A scientific journey (2015) (33)
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells. (1993) (32)
Erysipelothrix rhusiopathiae bacteremia presenting as septic shock. (1985) (32)
The Ba fragment of complement factor B inhibits human B lymphocyte proliferation. (1990) (32)
PEPFAR - 15 Years and Counting the Lives Saved. (2018) (32)
Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cells. (2012) (32)
Effect of anti‐V3 antibodies on cell‐free and cell‐to‐cell human immunodeficiency virus transmission (1995) (32)
The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 (2013) (32)
Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. (1991) (31)
Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis. (1979) (31)
Maturational characteristics of HIV-specific antibodies in viremic individuals. (2016) (31)
Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection (1991) (31)
GATA-1 transcription factor transactivates the promoter for CCR5, a coreceptor for human immunodeficiency virus type 1 entry. (1999) (31)
Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120 (2018) (31)
Cytokine regulation of acute and chronic HIV infection in vitro: from cell lines to primary mononuclear cells. (1994) (31)
Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates (1982) (31)
Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts (2007) (31)
Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection (1989) (31)
Selective activation of antigen-specific human B cells in recently immunized individuals by nonspecific factors in the absence of antigen. (1983) (31)
Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process. (1984) (30)
Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities. (1976) (30)
HLA Typing in Patients with Wegener Granulomatosis (1995) (30)
CT of the paranasal sinuses and orbits in patients with Wegener's granulomatosis. (1987) (30)
Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal. (2010) (30)
The Idiopathic Hypereosinophilic Syndrome (2020) (30)
Human T cell leukemia/lymphoma virus-infected antigen-specific T cell clones: indiscriminant helper function and lymphokine production. (1985) (30)
Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation (1981) (29)
Treatment with IL-7 Prevents the Decline of Circulating CD4+ T Cells during the Acute Phase of SIV Infection in Rhesus Macaques (2012) (29)
Granulomatous vasculitides: distinct but related. (1977) (29)
Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS). (1984) (29)
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapy. (2000) (29)
B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells. (1987) (29)
The Role of Integrin α4β7 in HIV Pathogenesis and Treatment (2018) (29)
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes. (1996) (28)
25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances (2007) (28)
Leukemic B-cell precursors constitutively express functional receptors for human interleukin-1. (1989) (28)
An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals (2019) (28)
In vitro idiotypic suppression of chronic lymphocytic leukemia lymphocytes secreting monoclonal immunoglobulin M anti-sheep erythrocyte antibody. (1980) (28)
Relationship of the genes for Chediak-Higashi syndrome (beige) and the T-cell receptor gamma chain in mouse and man. (1987) (28)
Human astrocytes stimulate HIV-1 expression in a chronically infected promonocyte clone via interleukin-6. (1991) (28)
Paranasal sinus obliteration in Wegener granulomatosis. (1982) (28)
Differentiation of Promonocytic U937 Subclones into Macrophagelike Phenotypes Regulates a Cellular Factor(s) Which Modulates Fusion/Entry of Macrophagetropic Human Immunodeficiency Virus Type 1 (1998) (28)
A Framework for Decisions About Research with HPAI H5N1 Viruses (2013) (28)
Human lymphocyte surface markers. (1982) (28)
Nef, macrophages and B cells: a highway for evasion (2010) (28)
Nonspecific interstitial pneumonitis in patients with AIDS: radiologic features. (1987) (28)
The complex challenges of HIV vaccine development require renewed and expanded global commitment (2019) (27)
Anopheles gambiae Genome: Completing the Malaria Triad (2002) (27)
The expanding global health agenda: a welcome development (2007) (27)
Differential effects of interleukin 2 vs B cell growth factor on human B cells. (1988) (27)
Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals (2011) (27)
Lymphomatoid Granulomatosis and Angiocentric Lymphoma: A Spectrum of Post-Thymic T-Cell Proliferations (1989) (27)
Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens. (2016) (27)
Lymphokine Production by B Cells from Normal and HIV‐Infected Individuals (1992) (27)
Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems. (1981) (27)
HYDROCORTISONE, PREDNISONE, ENDOTOXIN, AND ETIOCHOLANOLONE (1975) (27)
Activated human T cells can present alloantigens but cannot present soluble antigens. (1985) (27)
An HIV cure: feasibility, discovery, and implementation. (2014) (26)
The direct effects of interleukin 1, interleukin 2, Interferon-α, Interferon-γ, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells (1985) (26)
Immunolgic reactivity of the lung. V. Regulatory effects of antibody on the pulmonary immune response to locally administered antigen. (1977) (26)
HIV/AIDS in 1998--gaining the upper hand? (1998) (26)
HTLV type I Tax activation of the CXCR4 promoter by association with nuclear respiratory factor 1. (1999) (26)
Wegener's Granulomatosis (1980) (26)
CORTICOSTEROIDS IN HUMAN LYMPHOCYTE‐MEDIATED CYTOTOXIC REACTIONS: EFFECTS ON THE KINETICS OF SENSITIZATION AND ON THE CYTOLYTIC CAPACITY OF EFFECTOR LYMPHOCYTES IN VITRO (1977) (25)
Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies (2004) (25)
Filarial parasite-specific T cell lines: induction of IgE synthesis. (1985) (25)
Mechanisms of Lymphocyte Activation and Immune Regulation (1987) (25)
Opioid Injection in Rural Areas of the United States: A Potential Obstacle to Ending the HIV Epidemic. (2019) (24)
Comparative analysis of constitutive cytokine expression in peripheral blood and lymph nodes of HIV-infected individuals. (1994) (24)
Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma. (1984) (24)
Activation of human B lymphocytes. IX. Modulation of antibody production by products of activated macrophages. (1978) (24)
Subpopulations of human T lymphocytes. (1980) (24)
Retinal leakage in retinal vein occlusion: reduction after hyperbaric oxygen. (1989) (24)
Immunological reactivity of the lung: VII. Effect of corticosteroids and cyclophosphamide on the Fc receptor function of alveolar macrophages (1977) (24)
Elevated levels of tumor necrosis factor-alpha in Zairian neonate plasmas: implications for perinatal infection with the human immunodeficiency virus. (1994) (24)
Induction of HIV-1 replication by allogeneic stimulation. (1999) (24)
Kaposi's Sarcoma of the Head and Neck in the Acquired Immune Deficiency Syndrome (1984) (24)
Encyclopedia of pestilence, pandemics, and plagues (2008) (24)
Diagnostic and therapeutic aspects of the surgical approach to Wegener's granulomatosis. (1979) (24)
Neoplasm and systemic vasculitis: a case report. (1982) (24)
Biodefence on the research agenda (2003) (24)
Basic science: Bedrock of progress. (2016) (23)
In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements. (1984) (23)
Concomitant pulmonary aspergillosis and nocardiosis in a patient with chronic granulomatous disease of childhood. (1984) (23)
The global challenge of infectious diseases: the evolving role of the National Institutes of Health in basic and clinical research (2005) (23)
Biomedical research--an integral component of national security. (2004) (23)
Computer Assisted Tomography of Orbital Lesions in Wegener's Granulomatosis (1978) (23)
Glucocorticoids synergize with tumor necrosis factor alpha in the induction of HIV expression from a chronically infected promonocytic cell line. (1993) (23)
Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function. (1984) (23)
Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals. (1976) (23)
The immune adherence receptor: dissociation between the expression of erythrocyte and mononuclear cell C3b receptors. (1975) (23)
Improvement of antibody functionality by structure-guided paratope engraftment (2019) (23)
Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor. (1990) (23)
Familial vasculitis: report of 2 families. (1994) (23)
The Critical Role of Biomedical Research in Pandemic Preparedness. (2017) (22)
The modulation of membrane Ia on human B lymphocytes. (1985) (22)
Visual and auditory anomalies in Chediak-Higashi syndrome. (1983) (22)
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit (2021) (22)
AIDS: Let Science Inform Policy (2011) (22)
The clinical use of glucocorticoids. (1983) (22)
Human trials of AIDS vaccines: current status and future directions (1989) (22)
Immunoblastic sarcoma of the central nervous system in a patient with lymphomatoid granulomatosis (1978) (22)
Analysis of the expression of the 4F2 surface antigen in normal and neoplastic fibroblastic human cells of embryonic and adult origin. (1985) (22)
Cytokine regulation of HIV expression. (1990) (22)
Increased expression of HLA-DR antigens in hydrocortisone-treated monocytes. (1984) (22)
Immunopathology and pathogenesis of human immunodeficiency virus infection. (1991) (21)
Characterization of a T4+/Leu-8+ T cell clone that directly helps B cell Ig production by secreting B cell differentiation factor. (1985) (21)
Emerging infectious diseases: a clear and present danger to humanity. (2004) (21)
Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection (2019) (21)
Host defense against Mycobacterium-avium complex. (1988) (21)
Lymphocyte-mediated cytotoxicity against human allogeneic and autologous lymphoid targets after concanavalin A-activation of cytotoxic effector cells. (1977) (21)
Host-based antipoxvirus therapeutic strategies: turning the tables. (2005) (21)
Virologic and immunologic events in primary HIV infection (2004) (21)
NIAID workshop on immunity to malaria: addressing immunological challenges (2009) (21)
Less common manifestations and presentations of Wegener's granulomatosis. (1992) (21)
Acute Flaccid Myelitis: Something Old and Something New (2019) (21)
Herpes zoster in patients with treated Wegener's granulomatosis. A possible role for cyclophosphamide. (1980) (20)
Identification of a receptor for high molecular weight human B cell growth factor. (1988) (20)
Investing to meet the scientific challenges of HIV/AIDS. (2009) (20)
Human B lymphocyte function: cell triggering and immunoregulation. (1982) (20)
Classification and Prospective Clinical Experience (1986) (20)
Cardiovascular effects and safety of intravenous and intramuscular pentamidine isethionate. (1987) (20)
Optimal immunity to HIV--natural infection, vaccination, or both? (1991) (20)
Immunological reactivity of the lung. IV. Effect of cyclophosphamide on alveolar macrophage cytotoxic effector function. (1977) (20)
Targeting α4β7 integrin reduces mucosal transmission of SIV and protects GALT from infection (2014) (20)
Characterization of the direct effects of cyclophosphamide on cell-mediated immunological responses. (1977) (20)
Transmission of drug-resistant strains of HIV-1: unfortunate, but inevitable (1999) (20)
Immunology research: challenges and opportunities in a time of budgetary constraint (2007) (20)
Lymphocyte populations in acute viral gastroenteritis (1976) (20)
An HIV Vaccine: Mapping Uncharted Territory. (2016) (20)
The AIDS research model: implications for other infectious diseases of global health importance. (2001) (20)
Dramatic remissions in severe systemic necrotizing vasculitis (SNV) with cyclophosphamide (CY) therapy (1979) (19)
Emerging Pandemic Diseases: How We Got to COVID-19 (2020) (19)
The hypereosinophilic syndrome: dramatic response to therapeutic intervention. (1977) (18)
HIV cure research: a formidable challenge (2015) (18)
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7 (2018) (18)
Pandemic Zika: A Formidable Challenge to Medicine and Public Health (2017) (18)
Emerging and Reemerging Infectious Diseases: The Dichotomy Between Acute Outbreaks and Chronic Endemicity (2017) (18)
Thoracic manifestations of the acquired immune deficiency syndrome. (1984) (18)
MAdCAM costimulation through Integrin-α4β7 promotes HIV replication (2018) (18)
Refocusing Research on Sexually Transmitted Infections. (2019) (18)
Cell-Mediated Cytotoxicity in Recurrent Herpes Simplex Virus Infections in Man (1977) (17)
HIV-1 gp120: A Target for Therapeutics and Vaccine Design. (2015) (17)
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques. (2021) (17)
T CELL DEPLETION OF HUMAN BONE MARROW USING MONOCLONAL ANTIBODY AND COMPLEMENT‐MEDIATED LYSIS (1983) (17)
Leukotriene C4 produced by a human T-T hybridoma suppresses Ig production by human lymphocytes. (1988) (17)
COVID-19: The therapeutic landscape (2021) (17)
Human bone marrow lymphocytes. III. Polyclonal activation of B lymphocytes in human bone marrow measured by a direct plaque-forming cell assay. (1977) (16)
The Role of US Government Agencies in Vaccine Research And Development (1998) (16)
Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line. (1986) (16)
Apparent direct cellular cytotoxicity mediated via cytophilic antibody. Multiple Fc receptor bearing effector cell populations mediating cytophilic antibody induced cytotoxicity. (1977) (16)
Human B-lymphocyte function : activation and immunoregulation (1982) (16)
Short Communication HTLV Type I Tax Activation of the CXCR4 Promoter by Association with Nuclear Respiratory Factor 1 (1999) (16)
Trapped but still dangerous (1995) (16)
Analysis of Fcγ receptors on human peripheral blood leukocytes by flow microfluorometry. I. Receptor distributions on monocytes, Tγ cells and cells labeled with the 3A1 anti‐T cell monoclonal antibody (1982) (16)
Early treatment of SIV plus macaques with an alpha(4)beta(7) mAb alters virus distribution and preserves CD4(+) T cells in later stages of infection (15)
The world must build on three decades of scientific advances to enable a new generation to live free of HIV/AIDS. (2012) (15)
MSM, AIDS research activism, and HAART (2012) (15)
Integrin alpha(4)beta(7) expression on peripheral blood CD4(+) T cells predicts HIV acquisition and disease progression outcomes (15)
Species-Specific Differences in the Expression and Regulation of α4β7 Integrin in Various Nonhuman Primates (2015) (15)
Comprar Harrison's Principles of Internal Medicine, Self-Assessment and Board Review | Joseph Loscalzo | 9780071496193 | Mcgraw-Hill Education (2008) (15)
The Chronically Infected Promonocytic Cell Line U1: A Model of HIV Expression Regulated by Cytokines (1993) (14)
Wegener's granulomatosis. (1982) (14)
Corticosteroids in autoimmune disease. (1983) (14)
Transforming growth factor-beta is a potent negative regulator of human lymphocytes. (1991) (14)
Diffuse histiocytic lymphoma in a patient treated with cyclophosphamide for Wegener's granulomatosis. (1984) (14)
Suppression of antibody synthesis. I. Evidence for a circulating inhibitor of antibody synthesis demonstrable at the cellular level. (1971) (14)
AIDS in 1996. Much accomplished, much to do. (1996) (14)
A phase I trial of recombinant human interferon-γ in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS) (1989) (14)
Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward (2012) (14)
Reimagining the Research Approach to Tuberculosis† (2018) (14)
CXCR4/IgG-expressing plasma cells are associated with human gastrointestinal tissue inflammation. (2014) (14)
Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation. (1980) (14)
Development and characterization of interleukin-2-independent antigen-specific human T cell clones that produce multiple lymphokines. (1984) (13)
Development of a human T-T cell hybridoma secreting B cell growth factor (1982) (13)
Activation, proliferation, and differentiation of circulating B cells in autoimmune thyroid disease. (1985) (13)
AIDS–challenges to basic and clinical biomedical research (1989) (13)
Buerger's disease in a young woman. (1986) (13)
An Historical Antecedent of Modern Guidelines for Community Pandemic Influenza Mitigation (2009) (13)
NIH Response to Open Letter (2005) (13)
Current therapy in allergy and immunology 1983-1984 (1983) (13)
Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia. (1989) (13)
Harrison Principios De Medicina Interna, 2 Vols. + Dvd 18ª Ed. (2012) (13)
Bone Marrow Plasma Cells Are a Primary Source of Serum HIV-1–Specific Antibodies in Chronically Infected Individuals (2015) (13)
Classics in medicine (1994) (13)
IMMUNOLOGICAL FEATURES OF WEGENER'S GRANULOMATOSIS (1974) (13)
A Centenary Tale of Two Pandemics: The 1918 Influenza Pandemic and COVID-19, Part I. (2021) (13)
Short Communication: The Role of Dendritic Cells in the Infection of CD4+ T Cells with the Human Immunodeficiency Virus: Use of Dendritic Cells from Individuals Homozygous for the Δ32CCR5 Allele as a Model (1998) (13)
Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation. (1981) (13)
The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans (1985) (13)
Dendritic cells express and use multiple HIV coreceptors. (1997) (13)
The Concept of Classical Herd Immunity May Not Apply to COVID-19 (2022) (13)
Facial erysipelas in the immunocompromised host. Report of two cases. (1981) (13)
Immunology of aids: Approaches to understanding the immunopathogenesis of HIV infection (1989) (13)
Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics (2021) (13)
Host factors that affect sexual transmission of HIV. (1998) (12)
Pulmonary vasculitis. (1986) (12)
Host factors in the pathogenesis of HIV disease. (1996) (12)
The Extended Impact of Human Immunodeficiency Virus/AIDS Research (2018) (12)
Kinetics of plasma HIV rebound in the era of modern antiretroviral therapy. (2020) (12)
Therapeutic approaches to patients with AIDS. (1985) (12)
Regulation of human B-cell activation, proliferation, and differentiation by soluble factors (1984) (12)
Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles. (2019) (12)
Activation of human B lymphocytes. XV. Spontaneously occurring and mitogen-induced indirect anti-sheep red blood cell plaque-forming cells in normal human peripheral blood. (1980) (12)
Wegener's granulomatosis: studies in eighteen patients and a review of the literature. 1973. (1994) (12)
Progress in drug therapies for HIV infection. (1988) (12)
The acquired immune deficiency syndrome. The ever-broadening clinical spectrum. (1983) (12)
Immunological reactivity of the lung II. Cytotoxic effector function of pulmonary mononuclear cell subpopulations. (1976) (12)
The vasculitides. (1981) (12)
Early idiopathic hemochromatosis with absent stainable bone marrow iron stores (1978) (11)
Diadenosine 5',5'''-p1,p4-tetraphosphate deficiency in blood platelets of the Chédiak-Higashi syndrome. (1985) (11)
Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques (2019) (11)
Vasculitis: new insights amid old enigmas. (1979) (11)
Quantitative and qualitative effects of cyclophosphamide administration on circulating polymorphonuclear leucocytes. (1976) (11)
The T cell receptor V beta repertoire in HIV-1 infection and disease. (1993) (11)
Cytokine Cascades in HIV Infection (1996) (11)
Stages in the progression of HIV infection in chimpanzees. (1987) (11)
Pharmacokinetics of lymphocyte-derived and recombinant DNA-derived interleukin-2 after intravenous administration to patients with the acquired immunodeficiency syndrome. (1985) (11)
Smallpox immunization in the 21st century: the old and the new. (2003) (11)
The Chediak-Higashi gene in humans. III. Studies on the mechanisms of NK impairment. (1983) (11)
Erratum: Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates (Proceedings of the National Academy of Sciences of the United States of America (December 9, 2003) 100, 25 (15011-15016)) (2004) (11)
Differential sensitivity of human lymphocyte subpopulations to azathioprine. (1979) (11)
Corticosteroid-induced modulation of immunoglobulin secretion by human B lymphocytes: potentiation of background mitogenic signals. (1982) (11)
Immunologic aspects of the acquired immunodeficiency syndrome (1985) (11)
Human Immunodeficiency Virus Type 1 (HIV-1) Non-B Subtypes Are Similar to HIV-1 Subtype B in that Coreceptor Specificity Is a Determinant of Cytopathicity in Human Lymphoid Tissue Infected Ex Vivo (2001) (11)
Radiation therapy of midline granuloma (1977) (11)
STIMULATION OF PHAGOCYTOSIS BY A T CELL LYMPHOMA-DERIVED LYMPHOKINE (1982) (11)
Reaching everyone, everywhere with life-saving vaccines (2017) (11)
Nocardia astéroïdes sinusitis. Presentation as a trimethoprim-sulfamethoxazole responsive fever of unknown origin. (1977) (10)
Focusing to achieve a world without AIDS. (2015) (10)
Human T cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin 2 by differentiation in the absence of enhanced proliferation (1985) (10)
Suppression of antibody synthesis. II. The effect of carrier-specific cellsupon haptenic competition. (1971) (10)
The Role of the Virtuous Investigator in Protecting Human Research Subjects (2016) (10)
Chromobactehum violaceum Infectious and Chronic Granulomatous Disease (1983) (10)
Evidence for susceptibility of intrathymic T cell precursors to human immunodeficiency virus infection: a mechanism for T4 (CD4) lymphocyte depletion. (1990) (10)
Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma. (1986) (10)
Combination therapy for HIV infection: getting closer. (1992) (10)
Benchmarks for antiretroviral therapy. (2000) (10)
Antigen-induced human T cell help. Precursor frequency, radiation sensitivity, and allogeneic effects. (1983) (10)
Harrison's Gastroenterology and Hepatology (2010) (10)
Interferon‐γ induces light chain synthesis in interleukin 2 stimulated human B cells (1986) (10)
AIDS: immunopathogenic mechanisms and research strategies. (1987) (10)
Evolution in the structure and distribution of 4F2‐antigen from the oncofetal to the adult phenotype of human fibroblasts (1986) (9)
An elusive soluble suppressor (1995) (9)
Update on and Future Directions for Use of Anti–SARS-CoV-2 Antibodies: National Institutes of Health Summit on Treatment and Prevention of COVID-19 (2021) (9)
Lithium carbonate for recurrent fever and neutropenia. (1981) (9)
Defective polymorphonuclear leukocyte chemotaxis and bactericidal capacity in a boy with recurrent pyogenic infections. (1976) (9)
The relationship between immunization and circulating antigen-specific plaque-forming cells. (1983) (9)
Host defense againstMycobacterium-avium complex (1988) (9)
Role of Implementation Science: Linking Fundamental Discovery Science and Innovation Science to Ending the HIV Epidemic at the Community Level. (2019) (9)
The human autologous mixed lymphocyte reaction. II. Analysis of activation and proliferation. (1982) (9)
Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease (1982) (9)
Human B-cell proliferation in response to recombinant interleukin 2 is not due to T-cell help. (1985) (9)
Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease (1982) (9)
Acquired immunodeficiency syndrome may present as severe restrictive lung disease. (1989) (9)
NIH conference. The acquired immunodeficiency syndrome: an update. (1985) (9)
Different requirements for Ia-bearing accessory cells in mitogen versus antigen induction of human B-cell responses. (1983) (9)
Bioterrorism: defining a research agenda. (2002) (9)
Ending the HIV Epidemic in the United States: Closing the Implementation Gaps (2018) (8)
Current Concepts Influenza Vaccines for the Future (2010) (8)
IMMUNOPATHOGENESIS OF HIV INFECTION 1 (1998) (8)
Antiretroviral therapy and immunologic reconstitution in AIDS. (1987) (8)
Achieving an AIDS-free World: Science and Implementation (2013) (8)
The activation, proliferation, and differentiation of human B lymphocytes. (1987) (8)
Harrison's Infectious Diseases, 2/E (2013) (8)
Current strategies in the treatment of HIV infection. (2002) (8)
The search for an HIV vaccine, the journey continues (2020) (8)
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to alpha4beta7 (2018) (8)
Modulation of human B cell responses by a monoclonal antibody to an activation antigen 4F2. (1984) (8)
MAdCAM costimulation through Integrin-alpha(4)beta(7) promotes HIV replication (2018) (8)
B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor (1986) (8)
Preface: Evolving Ethical Issues Over the Course of the AIDS Pandemic (2012) (8)
Continuous flow leukapheresis induces expression of stress genes in lymphocytes: impact on microarray analyses. (2003) (8)
Idiopathic midline granuloma. (1982) (7)
Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection. (2019) (7)
Human immunodeficiency virus disease : AIDS and related disease (2008) (7)
Ending the HIV Pandemic: Optimizing the Prevention and Treatment Toolkits. (2019) (7)
Antiviral immunity in HIV-1 infected long-term non-progressors (LTNPs) (1996) (7)
The development of an AIDS vaccine: progress and promise. (1988) (7)
Activated cytotoxic lymphocytes in lymph nodes from human immunodeficiency virus (HIV) 1‐infected patients: a light and electronmicroscopic study (1997) (7)
WEGENER GRANULOMATOSIS. REPLY (1992) (7)
Corticosteroids and circulating lymphocytes. (1975) (7)
Synergy of helper factors in the differentiation of in vivo-preactivated antigen-specific human B cells. (1985) (7)
Correlation with increased IL-7 (2016) (7)
Salmonella Susceptibility (2010) (7)
200 Leukotriene B4, C4 and D4 generation by human eosinophils (1983) (7)
The revolution in clinical immunology. (1981) (7)
Dengue: The Continual Re-Emergence of a Centuries-Old Disease (2013) (7)
Comprar Harrison's Infectious Diseases | Anthony S. Fauci | 9780071702935 | Mcgraw-Hill Education (2010) (7)
Achieving an AIDS-free world: science and implementation (2013) (7)
Chromobacterium violaceum infectious and chronic granulomatous disease. (1983) (7)
ddI--a good start, but still phase I. (1990) (7)
Suppression of the generation of human con A-induced cytotoxic effector cells by con A-activated suppressor cells. (1978) (7)
Both Memory and CD 45 RA 1 / CD 62 L 1 Naive CD 4 1 T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals (1999) (6)
Wegener's granulomatosis and other systemic granulomatous conditions. (1990) (6)
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin α4β7 and promotes cellular activation and infection. (2020) (6)
Síndromes de las vasculitis (2007) (6)
Antigen-specific human B-cell responses: modulation by immunoregulatory T-cell subsets. (1983) (6)
Comprar Harrison's Manual of Medicine | Dennis Kasper | 9780071477437 | Mcgraw-Hill Education (2009) (6)
Human immunodeficiency virus. Trapped but still dangerous. (1995) (6)
123 – The Immunology of Human Immunodeficiency Virus Infection (2015) (6)
Pillars Article: production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986. 163: 1037-1050. (2014) (6)
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy. (2021) (6)
Current Studies Examining Regulation of the Human B Cell Cycle (1987) (6)
lmmunoregulation in autoimmunity (1980) (6)
The pathology of idiopathic midline destructive disease (IMDD) in the eyelid. (1983) (6)
Histopathology of ocular changes in chronic granulomatous disease. (1983) (6)
Monocyte t cell interactions in the immuno regulation of human b cell reactivity (1980) (5)
CHAPTER 2 – POKEWEED MITOGEN-INDUCED PFC RESPONSES OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES: REGULATION OF B-CELL TRIGGERING (1979) (5)
Peripheral Neuropathy in Chediak-Higashi Syndrome (1986) (5)
HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics. (2021) (5)
NIH conference. Immunomodulators in clinical medicine. (1987) (5)
Glucocorticoid effects on circulating human mononuclear cells. (1979) (5)
Decade of Vaccines. Foreword. (2013) (5)
Overview of clinical syndromes and immunology of AIDS. (1984) (5)
Viral persistence in HIV infection: much known, much to learn. (2013) (5)
The Acquired Immune Deficiency Syndrome: The Ever-Broadening Clinical Spectrum. (1983) (5)
Therapeutic approach to the vasculitic syndromes. (1986) (5)
Association Between Human Immunodeficiency Virus Infection and Cardiovascular Diseases: Finding a Solution to Double Jeopardy. (2017) (5)
A platelet abnormality in the Chediak-Higashi syndrome of man (1976) (5)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
2005 Robert H. Ebert Memorial Lecture Emerging and Re-emerging Infectious Diseases: The Perpetual Challenge (2005) (5)
Comprar Harrison Principios De Medicina Interna, 2 Vols. + Dvd 18ª Ed. | Eugene Braunwald | 9786071507273 | MCGRAW HILL (2012) (5)
2019: A Banner Year for Tuberculosis Research. (2020) (5)
Addressing the Tuberculosis Epidemic: 21st Century Research for an Ancient Disease (2018) (5)
Introducción al sistema inmunitario (2007) (5)
Prolonged viral suppression with anti-HIV-1 antibody therapy (2022) (5)
Comprar Harrison's Manual Of Medicine 19th Ed. | D. Kasper | 9780071828529 | MCGRAW HILL (2016) (5)
Role of T-cell trafficking in the pathogenesis of HIV disease (2019) (5)
Meeting the Challenge of Epidemic Chikungunya. (2016) (5)
Advances in host defense mechanisms. Volume 1. Phagocytic cells. (1982) (5)
Immunogenic Properties of Human Gamma Globulin Free of Endotoxin Contamination (1971) (4)
Translating Research into Therapies (2012) (4)
Comprar Harrison Manual de Medicina Interna 18ed | Dan Longo | 9786071509505 | Mcgraw-Hill Interamericana (2013) (4)
Prevention of HIV Transmission Universal Voluntary Testing and Treatment for (2009) (4)
Transforming biomedical research to develop effective TB vaccines: the next ten years. (2012) (4)
11 The aids epidemic: Demographic aspects, population biology, and virus evolution (1998) (4)
15. Differential effects of in vivo hydrocortisone on human T cell subpopulations (1978) (4)
Chromobacterium violaceum infections and chronic granulomatous disease. (1983) (4)
The effects of interleukin-1, interleukin-2, alpha-interferon, and gamma-interferon on human B lymphocytes. (1984) (4)
Infection by HIV Chemokine Receptor 5 Expression and Cells : CXC Chemokine Receptor 4 and CC Progenitor + Peripheral Blood-Derived CD 34 (1998) (4)
In Memoriam: Robert M. Chanock, MD, 1924–2010. (2011) (4)
Refocusing Human Microbiota Research in Infectious and Immune-mediated Diseases: Advancing to the Next Stage. (2020) (4)
Biochemical and Biological Characterization of a Dodecameric CD 4-Ig Fusion Protein IMPLICATIONS FOR THERAPEUTIC AND VACCINE (2002) (4)
The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells. (1985) (4)
Catalysing HIV/TB research: a meeting report (2009) (4)
Idiopathic CD 4 + T Lymphocytopenia is Associated with Increases in Immature / Transitional B Cells and Serum Levels of IL-7 Short title : ICL linked to abnormal B cells and elevated IL-7 (2006) (4)
Demonstration of major histocompatibility complex restriction in man using an antigen-specific proliferating T cell clone. (1982) (4)
Early treatment of HIV-1 infection (1998) (4)
Head and neck manifestations of histiocytic medullary reticulosis (1978) (4)
Complete hematologic and hepatic recovery in a patient with chloramphenicol hepatitis-pancytopenia syndrome. (1982) (4)
Letter: Midline granuloma or Wegener's granulomatosis. (1976) (3)
Characterization of the cellular immune response following in vivo immunization with pneumococcal polysaccharides in man. (1983) (3)
AIDS: newer concepts in the immunopathogenic mechanisms of human immunodeficiency virus disease. (1995) (3)
Promethean thymus? (1998) (3)
Combination anti-HIV antibodies provide sustained virological suppression. (2022) (3)
Two-dimensional Echocardiographic Assessment of the Idiopathic Hypereosinophilic Syndrome (2005) (3)
Successful management of hepatic abscesses by percutaneous catheter drainage in chronic granulomatous disease. (1986) (3)
Human cyclic neutropenia (1981) (3)
The vasculitic syndromes. (1982) (3)
Emerging and Re-Emerging Infectious Diseases: The Perpetual Challenge to Global Health (2004) (3)
The Forgotten Forefather: Joseph James Kinyoun and the Founding of the National Institutes of Health (2012) (3)
The National Institute of Allergy and Infectious Diseases' asthma research programs: a retrospective. (2007) (3)
A Universal Flu Vaccine Is Vital. (2018) (3)
Impact of Biomedical Research on the AIDS Epidemic (1992) (3)
The role of dendritic cells in the infection of CD4+ T cells with the human immunodeficiency virus: use of dendritic cells from individuals homozygous for the delta32CCR5 allele as a model. (1998) (3)
CYTOLYTIC T LYMPHOCYTES IN MIXED LYMPHOCYTE CULTURE (1981) (3)
Immunologic aspects of cardiovascular disease. (1982) (3)
NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection. (1989) (3)
Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine (2021) (3)
B-cell abnormalities in AIDS. (1984) (3)
Audio Interview: A Covid-19 Conversation with Anthony Fauci. (2021) (3)
The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis. (1988) (3)
Thoracic mass lesions in immuno-incompetent patients. (1982) (3)
Dichotomy between antigen and mitogen induced t cell help in human b cell activation (1982) (3)
Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus (3)
Cytotoxic cellular immunity and cytomegalovirus lessons from studies of the acquired immunodeficiency syndrome and immunosuppressed allograft recipients (1985) (3)
Immunopathogenic mechanisms of human immunodeficiency virus disease: implications for therapy. (1995) (3)
Functional and biochemical characterization of B-cell differentiation factor (BCDF) produced by an HTLV-I-transformed human T-cell clone and demonstration of specific binding of the factor to a BCDF responsive cell line. (1987) (3)
Activation of human B lymphocytes. XVII. Synergy between nonspecific and specific signals in the antigen-specific responses of human B cells. (1981) (3)
Fighting infectious disease threats via research: a talk with Anthony S. Fauci. (1996) (3)
The effect of in vivo hydrocortisone (OHC) on in vitro lymphocyte function in humans (1973) (3)
Differentiation of Promonocytic U 937 Subclones into Macrophagelike Phenotypes Regulates a Cellular Factor ( s ) Which Modulates Fusion / Entry of Macrophagetropic Human Immunodeficiency Virus Type 1 (1997) (3)
Biochemical characterization of human B-cell growth factor (BCGF)☆☆☆ (1982) (3)
T cell homeostasis in HIV infection: part of the solution, or part of the problem? (1993) (3)
Letter: Monocytopenia after prednisone. (1975) (2)
Defining and Defeating the Intolerable Burden of Malaria III. Progress and Perspectives (2007) (2)
Immunoregulation in autoimmunity. (1981) (2)
Clinical Effects of Immunosuppressive Agents: Targets and Mechanisms (1983) (2)
Infectious complications complications of cyclophosphamide treatment for vasculitis (1989) (2)
From mRNA sensing to vaccines (2021) (2)
The Spectrum of Vasculitis (2020) (2)
CHAPTER 19 – EFFECT OF HYDROCORTISONE ON THE KINETICS AND FUNCTION OF PERIPHERAL BLOOD IMMUNOREGULATORY CELLS IN MAN (1979) (2)
Interferon-gamma induces light chain synthesis in interleukin 2 stimulated human B cells. (1986) (2)
NIH research: Think globally (2015) (2)
Response to: "Rescuing the NIH before it is too late". (2006) (2)
Granulomatous hepatitis. (1976) (2)
Victories against AIDS have lessons for COVID-19. (2021) (2)
Blocking α4β7 integrin delays viral rebound in SHIVSF162P3-infected macaques treated with anti-HIV broadly neutralizing antibodies (2021) (2)
Immunity to Influenza: Catching a Moving Target To Improve Vaccine Design (2019) (2)
Fitting a vaccine into the HIV prevention landscape (2021) (2)
Wegener's granulomatosis. (1991) (2)
An HIV vaccine: breaking the paradigms. (1996) (2)
Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases (2003) (2)
Authorsʼ reply to correspondence by Le and Farrar (2011) (2)
Heparin and lymphocyte kinetics: use in studies on the mechanisms of corticosteroid-induced peripheral lymphocytopenia. (1976) (2)
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2016) (2)
KL01 Ending the HIV/AIDS Pandemic: From Scientific Advances to Public Health Implementation (2013) (2)
Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells. (1978) (2)
Surgical aspects of systemic necrotizing vasculitis. (1985) (2)
The Jules Bordet Lecture. Immunopathogenesis of HIV infection. (1993) (2)
US puts flu vaccines on trial. Interview by Declan Butler. (2009) (2)
Persistently elevated abnormal B‐cell subpopulations and anti‐core antibodies in patients co‐infected with HIV/HCV who relapse (2015) (2)
Production of monoclonal antibody recognizing a subpopulation of human B lymphocytes producing B cell growth factor (BCGF) (1986) (2)
[The nephrotic syndrome in congenital syphilis]. (1981) (2)
Dengue vaccine clinical trials in India - An opportunity to inform the global response to a re-emerging disease challenge. (2019) (2)
Production of phagocytosis-inducing factor and expression of 4B4 antigen by cloned human T cells before and after transformation with HTLV-I. (1988) (2)
Strategies for Preventing HIV Transmission—Reply (2009) (2)
Research sheds light on treatment interruption. (2001) (2)
The scientific agenda for AIDS. (1988) (2)
N-acetyl-cysteine is a potent suppressor of human immunodeficiency virus transcription in persistently infected cells. (1992) (2)
Pathogenic Mechanisms of HIV Disease: The Role of Viral Replication and Immune Activation (2005) (2)
7 – Immunopathologic Mechanisms of Human Immunodeficiency Virus (HIV) Infection (1991) (2)
Cytokines and Immunoregulatory Factors in the Pathogenesis of HIV Infection: TNF Effects (1992) (2)
IMMUNOREGULATION OF HUMAN B LYMPHOCYTE FUNCTION BY PRODUCTS OF HYBRIDIZED AND CLONED T CELLS (1983) (1)
Plaque-forming cell assays for human B cells (1981) (1)
The ASCI, the spring meetings, and growing up in academic medicine: a personal perspective. (2008) (1)
Track A Basic Science (2012) (1)
117 Ending the HIV/AIDS Pandemic: A Realistic Goal (2012) (1)
Role of CD8+ T Lymphocytes in the Pathogenesis of HIV Infection (1992) (1)
Relationship between expression of Fcγ receptors or la antigens and cytolytic activities of alloactivated human T cells (1983) (1)
Effect of alternate day prednisone therapy on human lymphocyte subpopulations (1974) (1)
Host Factors in the Immunopathogenesis of HIV Disease (1995) (1)
Screening for HIV infection in sexually transmitted disease clinics. (1988) (1)
Battling Ebola: the virus and the fear. (2014) (1)
MAdCAM signaling through integrin α4β7 modulates surface expression of CCR5 and markers of CD4+ T cell activation. (2016) (1)
Regulation of Human B Cell Function (1988) (1)
103 HIV-1 gp120 Interactions With the Gut Homing Receptor Integrin α4β7 on CD4+ T Cells (2012) (1)
CD 8 ' T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity ( cytotoxic T lymphocyte / T-cell abnormalities ) (1)
EFFECT OF VIRUS INFECTION ON POLYMORPHONUCLEAR LEUCOCYTES (1977) (1)
H-106 Sustained ART-free HIV remission: Obstacles and opportunities (2018) (1)
Biomedical research in an era of unlimited aspirations and limited resources. (1996) (1)
Reply to Brundage and Shanks (2007) (1)
Harrison's 14 CD-ROM (2000) (1)
A new series on the revolution in immunology. (1987) (1)
MULTIPLE SUBPOPULATIONS OF LYMPHOID CELLS REGULATING HUMAN B CELL FUNCTION (1979) (1)
A living history of AIDS vaccine research. (2009) (1)
Activation and immunoregulation of human B lymphocytes. (1984) (1)
Communications Antigenic Competition at the Cellular Level: Response of Rabbit Lymph Node Cells to the Trinitrophenyl and P-Arsanilie Haptens (1971) (1)
Temporal Aspects Of Hiv Dna And Rna Synthesis And Tissue Distribution During Hiv Infection (1993) (1)
Alternative cytokines in the immunoregulation of the human B cell cycle. (1989) (1)
Letter: Immunological features of Wegener's granulomatosis. (1974) (1)
Relationship between the Size of the Human Immunodeﬁciency Virus Type 1 (HIV-1) Reservoir in Peripheral Blood CD4 + T Cells and CD4 + :CD8 + T Cell Ratios in Aviremic HIV-1– Infected Individuals Receiving Long-Term Highly Active Antiretroviral Therapy (2002) (1)
New Science Aimed at an Ancient Killer (1995) (1)
Regulation of Human B Cell Growth (1989) (1)
Chapter 257. Tumours of the large and small intestine (1994) (1)
Development of Effective Vaccines Commentary against Pandemic Influenza (2006) (1)
Wegener granulomatosis [3] (1992) (1)
Inhibition of polyclonal B cell activation by hydrocortisone (HC)-sensitive suppressor monocytes in sarcoidosis (1978) (1)
C105 Glycosylation in HIV Transmission (2013) (1)
Early idiopathic hemochromatosis with absent stainable bone marrow iron stores. (1978) (1)
Expression of Chemokine Receptors CXCR4 (1998) (1)
Infection of CD4+ Primary Cell Lines and Induction of HIV (1993) (1)
P-C19 The in vivo effects of Anti-a4b7 in rhesus macaques during acute and chronic infection (2017) (1)
Comprar Harrison's Rheumatology | Carol Langford | 9780071741439 | Mcgraw-Hill Education (2010) (1)
Characterization of an early thymocyte cell line which is chronically infected with the human immunodeficiency virus. (1991) (1)
37 – Human T Cell Clones Reactive with Soluble Antigens: Methodology, Specificity, and MHC Restriction (1982) (1)
Human T4+ lymphocytes produce a phagocytosis-inducing factor distinct from α- and γ-interferon (1985) (1)
Reply to kilbourne. (2009) (1)
Early human B cell signatures of the primary antibody response to mRNA vaccination (2022) (1)
Response: HIV Quasispecies and Resampling. (1996) (1)
HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells (2006) (1)
Individuals and CCR 5 in HIV-1-Infected and Uninfected Expression of Chemokine Receptors CXCR 4 (1998) (1)
Investing To Meet The Scientific Challenges Of (2009) (1)
Immunologic Reactivity of the Lung (2015) (1)
Efficient macrophage isolation of human immunodeficiency virus from peripheral blood leukocytes from healthy seropositive individuals: implications for cell tropism. (1989) (1)
Emerging concepts in the management of vasculitic diseases. (1994) (1)
OBJECTIVE PROGNOSTIC FACTORS FOR PATIENTS WITH PNEUMOCYSTIS CARINII PNEUMONIA AND THE ACQUIRED IMMUNODEFICIENCY SYNDROME (1987) (1)
US and Cuban Scientists Forge Collaboration on Arbovirus Research. (2018) (1)
The challenges of an HIV vaccine enterprise - Response (2004) (1)
Antigenic competition at the cellular level: response of rabbit lymph node cells to the trinitrophenyl and p-arsanilic hapTENS. (1971) (1)
Pharmacologic regulation of HIV expression. (1992) (1)
CCR5 Signal Transduction in Macrophages by Human Immunodeficiency Virus and Simian Immunodeficiency Virus Envelopes (2000) (1)
HIV prevention research: progress and challenges in the new millennium (1969) (1)
A view from Washington through the eyes of an AAP physician-scientist: 2007 Association of American Physicians George M. Kober Medal. (2007) (1)
Reversal with IL-10 Unbalanced Th1-Type T Cell Cytokine Pattern: T Cells Exhibiting an + CD4 + with HLA-DR Active Wegener's Granulomatosis Is Associated (1998) (1)
CHAPTER 23 – ABERRANT REGULATION OF B-CELL FUNCTION IN IMMUNOLOGICALLY MEDIATED DISEASES: SYSTEMIC LUPUS ERYTHEMATOSUS AND SARCOIDOSIS (1979) (1)
Reports on nevirapine threaten public health (2005) (1)
SARS-CoV-19’s actual initial cases in Wuhan, China and the impact of different interventions and imports in the pandemic. (2021) (0)
Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. (2004) (0)
IN VITRO REACTIVATION OF HIV-1 FROM LATENTLY INFECTED, RESTING CD4+ T CELLS BY HTLV-I-INFECTED CELL-DERIVED SOLUBLE FACTORS. (1999) (0)
Correction (2020) (0)
Introduction: Recent advances in the pathogenesis of human immunodeficiency virus infection (2004) (0)
Immunology of the acquired immunodeficiency syndrome. (1988) (0)
8:30 am OPEN SESSION: Welcome and NIH Director's Report (2014) (0)
Acquired Immune Deficiency Syndrome (2017) (0)
395 The effect of elective C-section, preterm labor and chorioamnionitis on fetal lymphocyte activation and susceptibility to HIV infection (2001) (0)
Facial Erysipelas in the Immunocompromised Host (2017) (0)
Interleukin 2 in H U M a N B Cell Function (2003) (0)
Ending the Global HIV Epidemic Begins at the Individual National Level: An Update from the United States (2020) (0)
The development of candidate HIV vaccines is expected to accelerate with 4 new partnerships between the private and public sectors announced by the US National Institute of Allergy and Infectious Diseases (NIAID) (2000) (0)
In memoriam: Albert Z. Kapikian, MD, 1930-2014. (2015) (0)
Concise review: the polypill in cardiovascular disease prevention (2007) (0)
Correction (2002) (0)
EARLY TREATMENT OF HIV-1 INFECTION. AUTHOR'S REPLY (1998) (0)
The Ebola Epidemic of 2014–2015 (2016) (0)
The Ohio State University Commencement Address by Anthony S. Fauci, Spring 2016 (2016) (0)
Thirty Years of HIV/AIDS: A Personal Journey (2011) (0)
C. EVERETT KOOP, 14 OCTOBER 1916 - 25 FEBRUARY 2013. (2014) (0)
Correction (2002) (0)
Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes (1983) (0)
Factors AssociatedWith AMR and Key Response Strategies (2016) (0)
Author index (1975) (0)
Factitious Fever and Self-Induced Infection (2020) (0)
Evolving Omicron Subvariants Are More Resistant to Antibody Therapy (2022) (0)
Correction (2019) (0)
Mechanisms of corticosteroid suppression of cytotoxic responses to alloantigens. (1976) (0)
Protection of rhesus macaques against vaginal SHIV challenges by VRC01 and an anti-α4β7 antibody (2018) (0)
Peering into the Infectious Future Of Emerging Infectious Diseases (2016) (0)
News in brief (1968) (0)
The explosive pandemic of Zika virus infection occurring throughout South America (2016) (0)
[Gentamicin in the treatment of respiratory tract infections in infancy]. (1969) (0)
Response : HIV Quasispecies and Resampling (1996) (0)
A renaissance for HIV vaccines? (2010) (0)
Current therapy in allergy, immunology, and rheumatology, 1985-1986 (1985) (0)
Brief DeBnitive Report (2003) (0)
25 years of AIDS (2006) (0)
A conversation with Tony Fauci. Interviewed by Ushma S. Neill. (2014) (0)
Biographical Memoirs: Maurice R. Hilleman (2007) (0)
Harrison. Gastroenterología y hepatología (2013) (0)
Human B-Cell Growth and Differentiation Factors Secreted by T-Cell Hybridomas (1985) (0)
Introduction to the Proceedings of the 4th World Congress on Tuberculosis (2003) (0)
Information , Inspiration and Advocacy for People Living with HIV / AIDS (0)
Chronic, Recurrent Small-Vessel Cutaneous Vasculitis-Reply (1982) (0)
The U.S. Presidential Election (2020) (0)
THE HEMODYNAMIC EFFECTS AND SAFETY OF IV PENTAMIDINE (1986) (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium; role of macrophages and lymphocytes as reservoirs of HIV-1 (1989) (0)
Antibody production in man : in vitro synthesis and clinical implications : proceedings of the Catharijne Conference on Immunology held in Utrecht, Holland on March 15-18, 1978 (1979) (0)
Nonspecific Interstitial Pneumonitis in Patients with (1987) (0)
Correction (2019) (0)
Harrison. Gastroenterología y hepatología (2013) (0)
Correction (2019) (0)
LIB: State-of-the-Art, from Equipment to Researchers (2005) (0)
[The treatment of small angles of strabismus with the aid of prisms]. (1968) (0)
on B Cell Costimulatory Function Deleterious Effect of HIV-1 Plasma Viremia (2003) (0)
In Memoriam: Edwin D. Kilbourne, MD, 1920–2011 (2011) (0)
Correction. (2020) (0)
Correction (2019) (0)
The acquired immunodeficiency syndrome (AIDS): an update. (1985) (0)
United States of America (1996) (0)
Relationship between expression of Fc gamma receptors or Ia antigens and cytolytic activities of alloactivated human T cells. (1983) (0)
Cytotoxic Effector Cells in the Bone Marrow of Normal Humans (1976) (0)
IMMUNOFLUORESCENT STUDIES IN ADULT CELIAC DISEASE TABLE (0)
Exogenous IL-2 Independent Antigen-Specific Human T Cells: Antigen-Specific Induction of Polyclonal B Cell Factors (1985) (0)
Contents, Vol. 51, 1976 (2004) (0)
PLAQUE FORMING CELL ASSAY FOR THE MEASUREMENT OF POLYCLONAL ACTIVATION OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES. CELLULAR REQUIREMENTS AND INTERACTIONS (1977) (0)
Correction (2020) (0)
Harrison's Online Updates (2001) (0)
[Evaluation of retinal correspondence with various tests in relation to the amount of the deviation in concomitant strabismus]. (1966) (0)
Correction (2004) (0)
Letter from Anthony Fauci to C. Everett Koop (1996) (0)
Monkeypox - Past as Prologue. (2022) (0)
Immuno-incompetent Patients* (2017) (0)
A Case Report of Wilson's Disease with Unusual Findings (2000) (0)
[Clinical and electroretinographic study of a case of coloboma of the optic nerve with absence of retinal vascularization]. (1968) (0)
The Haskins Lectureship in Science Policy, November 15, 2002 (2003) (0)
Finding Ways to Improve Patients’ Cancer Immunotherapy Response (2022) (0)
Detection Assays for HIV Proteins (2001) (0)
Anthony Fauci (2008) (0)
Acute Renal Failure (1987) (0)
Reply to Fedson (2009) (0)
E109 Ending the HIV/AIDS Pandemic: Research and Implementation (2013) (0)
Does Contrast Enhancement Predict Survival in Progressive Multifocal Leukoencephalopathy ? (2010) (0)
GENERAL DISCUSSION: CLINICAL IMPLICATIONS IN THE STUDY OF IN VITRO B CELL FUNCTION. II. (1979) (0)
Michael M. Frank: February 28, 1937–August 1, 2019 (2019) (0)
Live with Dr. Fauci (2020) (0)
Challenges and similarities in HIV, COVID-19 crises: a Q&A with Anthony Fauci, MD. (2020) (0)
Comprar Harrison's Gastroenterology And Hepatology 3rd Ed. | A. Fauci | 9781259835841 | MCGRAW HILL (2017) (0)
La necesidad de una vacuna universal contra la gripe (2018) (0)
Cell-mediated immunity-resistance to infection and so much more. (1977) (0)
Vaccination and the Lasker Awards: Enduring Legacies. (2015) (0)
PRESENTATION OF THE C. EVERETT KOOP HIV/AIDS HEALTH LEADERSHIP AWARD TO VADM C. EVERETT KOOP, MD, SCD, 13TH U.S. SURGEON GENERAL (2011) (0)
Macrophage-Tropic HIV Envelope T Cells by + Primary Human CD4 Receptor 5 and Focal Adhesion Kinase in Intracellular Association of CC Chemokine Induction of Phosphorylation and (1999) (0)
HIV-Infected Individuals and Effector Responses of B Cells in CpG Oligonucleotides Enhance Proliferative (2008) (0)
Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness (2022) (0)
Harrison perensiple of internal widicin (2012) (0)
Immunologic Approaches to the Therapy of Auto-Immune Salivary Gland Disease (1987) (0)
The Challenge of Pandemic Preparedness (2017) (0)
Book ReviewTextbook of Immunology (1979) (0)
Acknowledgment to Dartmouth Medical Center (1981) (0)
Fever of Unknown Origin-Reply (1978) (0)
Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected Ul cells : Inhibition of inductive effects by the interleukin 1 receptor antagonist ( cytokines / NF-icB / latency ) (2005) (0)
C. Everett Koop (2013) (0)
Book reviews (1993) (0)
Libraries with HIV-1-Positive Sera Epitopes by Screening Random Peptide Selection of HIV-Specific Immunogenic (1999) (0)
Comprar Harrison Manual de Medicina 19ª Ed. | D. Kasper | 9786071514097 | MCGRAW HILL (2017) (0)
Etiology of the acquired immunodeficiency syndrome (1985) (0)
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination (2022) (0)
Behavior Increased implementation of education programs and attempts to modify behavior Use of condoms and other barrier methods Treatment and prevention of drug and alcohol abuse Clean syringes (2007) (0)
Chapter 19. Mechanisms of Action of Glucocorticosteroids (1978) (0)
Letter from Anthony Fauci, National Institutes of Health to Harold Varmus (1985) (0)
Response: Correlates of Protective Viruses Damaging to HIV Infection. (1996) (0)
Correction (2016) (0)
The Effects of the AIDS Epidemic on the Safety of the Nation ' s Blood Supply (2006) (0)
News in brief (1966) (0)
The Effects of Interleukin 2, Gamma Interferon, and B Cell Differentiation Factor on the Differentiation of Human B Cells (1986) (0)
Connecting the dots on interferon responsiveness in HCV/HIV co-infection: The virus, the cytokine, the receptor and the gene (2009) (0)
Correction (2020) (0)
Correction (2019) (0)
Nurses play critical role in care of AIDS patients. (1987) (0)
Comprar Harrison Manual de Medicina 19ª Ed. | D. Kasper | 9786071514097 | MCGRAW HILL (2017) (0)
In the News (2008) (0)
PRELIMINARY RESULTS OF TRIMETREXATE (TMTX) ALONE OR IN COMBINATION WITH A SULFONAMIDE FOR THE TREATMENT OF PNEUMOCYSTIS PNEUMONIA IN AIDS PATIENTS (1987) (0)
Correction (2020) (0)
Etiology and immunopathogenesis of the acquired immunodeficiency syndrome (1986) (0)
Leukotriene C/sub 4/ (LTC/sub 4/) produced by a human T-T hybridoma suppresses pokeweed mitogen (PWM) induced immunoglobulin (Ig) production by human mononuclear cells (1986) (0)
Multifactorial Nature ofHumanImmunodeficiency Virus Disease: Implications forTherapy (2016) (0)
Correlates of Protective Viruses Damaging to HIV Infection (1996) (0)
Correction (2013) (0)
Effect of hydrocortisone (OHC) on the recirculating lymphocyte pool in man (1975) (0)
CDC Changes Rules for Counting Vaccinated Breakthrough Cases — Will Count Only Deaths and Hospitalizations (2022) (0)
Receptors Used as Coreceptors for HIV Entry Dendritic Cells Express Multiple Chemokine (1998) (0)
Evidence for CC-Chemokine-Dependent and to Replicate and Transmit HIV Infection : Stimulation on the Ability of Dendritic Cells Differential Effects of CD 40 Ligand / Trimer (1999) (0)
Protection against repeated vaginal SHIV challenges by a combination of VRC01 and an anti-α4β7 antibody (2018) (0)
Efficient inhibition of HIV entry-1 virus by a new fusion protein with cd4 (2002) (0)
a Coreceptor for HIV-1 Entry CXCR4, Suppresses, the Promoter Activity of USF/c-Myc Enhances, While Yin-Yang 1 (1999) (0)
ACTIVATION OF HUMAN B LYMPHOCYTES I. Direct P laque-Forming Cell Assay for the Measu remen t of Polyclonal Activation and Antigenic S t imula t ion of H u m a n B Lymphocytes (2003) (0)
Modulation of surface ia expression on human b lymphocytes (1984) (0)
Clinical characteristics and outcomes of South-East Asian patients with Takotsubo ( stress-induced ) cardiomyopathy (2003) (0)
Alteration of T lymphocyte subpopulations and presence of suppressor monocytes in tuberculosis (TB): The effects of anti-TB therapy (1979) (0)
Immunoregulation by Human Lymphocyte Subpopulations (1980) (0)
Comments on “ Cytomegalovirus ( CMV ) – Encoded UL 144 ( Truncated Tumor Necrosis Factor Receptor ) and Outcome of Congenital CMV Infection ” (2010) (0)
Correction (2019) (0)
Immunologic Approaches to the Therapy of Autoimmune Salivary Gland Disease (1987) (0)
Correction (2019) (0)
Cytotoxic effector capacity of bone marrow mononuclear cells. (1976) (0)
A Centenary Tale of Two Pandemics: The 1918 Inﬂuenza Pandemic and COVID-19, Part II. (2021) (0)
Activation and immunoregulation of human B lymphocyte function: implications in normal and disease states. (1983) (0)
Acquired Immune Deficiency Syndrome (AIDS): Basic findings (1985) (0)
Interleukin 2 in vitro corrects the defect in natural killer cell activity in the chediak higashi syndrome (1985) (0)
146 α4β7: A Newly Discovered Receptor for HIV (2009) (0)
Harrison Manual de Medicina Interna 18ed (2013) (0)
PULSE CYCLOPHOSPHAMIDE THERAPY FOR WEGENER'S GRANULOMATOSIS. AUTHOR'S REPLY (1991) (0)
NIH Summit on Anti-SARS-CoV-2 Antibodies for Treatment and Prevention of COVID-19—Lessons Learned and Remaining Questions (2021) (0)
Determination of Neutrophil Half-Life (1975) (0)
Harrison's Online Updates (2001) (0)
TGF-t 3 Suppresses IL-2-dependent T Cell Proliferation and Partially Inhibits IL-2R and Transferrin Receptor Expression (2003) (0)
Science for the common good. (2002) (0)
Opening Keynote Session (2008) (0)
Lithium carbonate for recurrent fever and neutropenia (1982) (0)
Guiding America through a pandemic (2022) (0)
Cytokine-induced Cell Death And Expression Of Hiv-1. Do Tumor Necrosis Factor-α (tnf-α) And Interferon-γ (ifn-γ) Selectively Kill Hiv-infected Cells? (1993) (0)
SEPARATION METHODS, SURFACE MARKERS AND CYTOTOXIC CAPABILITIES OF HUMAN EOSINOPHILS (1977) (0)
The T4 epitope is not required for a normal replicative cycle of human immunodeficiency virus. (1987) (0)
Global Health and Infectious Diseases: A Look to the Future (2008) (0)
SHORT COMMUNICATION Relationship of the Genes for Chediak-Higashi Syndrome (Beige) and the T-Cell Receptor y Chain in Mouse and Man (1987) (0)
news in brief (2002) (0)
and B Cell Helper Function (1984) (0)
Comprar Harrison’s Neurology in Clinical Medicine | Eugene Braunwald | 9780071741033 | Mcgraw-Hill Education (2010) (0)
StimulationInduction of HIV-1 Replication by Allogeneic (1999) (0)
Volume Information (1986) (0)
The Human B Cell Cycle: Activation, Proliferation, and Differentiation (1985) (0)
Point man. Interview by Jeff Berry. (2011) (0)
Future directions in human immunobiology. (1985) (0)
An interview with Anthony S. Fauci, MD. Interview by Mark Mascolini. (1996) (0)
1122 THE AMERICAN COLLEGE OF RHEUMATOLOGY 1990 CRITERIA FOR THE CLASSIFICATION OF GIANT CELL ARTERITIS (2010) (0)
World AIDS Day 2003. (2003) (0)
Constitutive production of a reverse transcriptase negative aids retrovirus particle (1987) (0)
Infectious complications of cyclophosphamide treatment for vasculitis. (1989) (0)
FOCUS Nov-06 Evidence-Based Conundrum (2007) (0)
Cytokines and cytokine antagonists control the replication of the human immunodeficiency virus (HIV) in vitro (1994) (0)
Prednisone dose in alternate day therapy (1975) (0)
Faith, Science, and Trust: African American Clergy & Community Conversation on COVID-19 (2021) (0)
Harrison's 14 (1999) (0)
Preface Harrison's Manual of Medicine (2019) (0)
LORENZO MORETTA , ANt ) (2003) (0)
The George M. Kober lecture. Basic immunology: the path to the delineation of the immunopathogenic mechanisms of HIV infection. (1988) (0)
E-102 Ending the HIV/AIDS pandemic: The convergence of treatment and prevention (2016) (0)
Comprar Harrison. Gastroenterología y hepatología | Anthony S. Fauci | 9786071508287 | Mcgraw-Hill Interamericana (2013) (0)
Cytomegalovirus-specific Cytotoxic Activities of Lymphocytes from Patients with the Acquired Immune Deficiency Syndrome (1983) (0)
Special Plenary Session (2004) (0)
Correction (2018) (0)
Orbital Manifestations of Wegenerʼs Granulomatosis on Computer Assisted Tomography (1977) (0)
What Will It Take to Respond to the Threat of Zika? (2016) (0)
Laudatio: in celebration of the 80th birthday of Maurice R. Hilleman, Ph.D. (2000) (0)
Live chat with Dr. Fauci discussing how to slow the spread of Covid (2020) (0)
The rapid spread of Zika virus through the Americas and its devastating consequences for pregnant women and infants have precip (2016) (0)
Researchers Identify New Strain of HIV Derived from Gorillas (2017) (0)
The Eff iciency o f Acute Infect ion o f CD 4 + T cells Is Markedly Enhanced in the Sett ing o f Ant igen (2003) (0)
Induction of polyclonal B cell activation and differentiation by the AIDS retrovirus (HTLV-III/LAV) (1986) (0)
Chapter 8 – Establishment of Human—Human and Human—Mouse B Cell Hybrids and Their Use in the Study of B Cell Activation (1983) (0)
THE ROLE OF SEQUENTIAL GALLIUM SCANNING IN AIDS PATIENTS DURING TREATMENT FOR PNEUMOCYSTIS CARINII PNEUMONIA (1987) (0)
Correction (2019) (0)
Letter from Anthony Fauci to Joshua Lederberg (1988) (0)
Correction (2006) (0)
of the Malignant T Cell in Sezary Syndrome and Mycosis Fungoides (1981) (0)
Harrison's Online Updates (2001) (0)
NIAID, AmFAR launch huge new study of HIV infection. (1991) (0)
Fifty years: advancing knowledge, improving health. (1999) (0)
Japan to allow limited human embryonic cloning (2008) (0)
Emerging Infectious Diseases—Reply (2005) (0)
Nonhuman Primates 7 Integrin in Various b 4 a and Regulation of Species-Specific Differences in the Expression (2015) (0)
The following protocols describe PCR amplification and polyacrylamide gel electrophoresis conditions for subtype determination of HIV-1 envelope (env) sequences using heteroduplex mobility assay (0)
SUMMARY OF WORKSHOP: HUMAN B CELL FUNCTION: RECENT ADVANCES, UNANSWERED QUESTIONS, AND FUTURE DIRECTIONS (1979) (0)
Harrison's Infectious Diseases; Second Edition. (2013) (0)
From the National Institutes of Health. (1995) (0)
Leading Edge Perspective EmergingPandemicDiseases : HowWeGottoCOVID-19 (0)
The revolution in the approach to allergic and immunologic diseases. (1985) (0)
Acquired immunodeficiency syndrome (AIDS). (1985) (0)
Emerging infectious diseases. Authors'reply (2005) (0)
Vitamin and Trace Mineral Deficiency and Excess (Chapter 326) (2018) (0)
Correction (1983) (0)
25 years of AIDS. Interview by Simon Noble. (2006) (0)
Contributors (2015) (0)
Introduction:Advances in the immunology of human immunodeficiency virus (HIV) infection (1993) (0)

This paper list is powered by the following services:

Other Resources About Anthony Fauci

What Schools Are Affiliated With Anthony Fauci?

Anthony Fauci is affiliated with the following schools: